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Elastin is responsible for elasticity and resiliency of force-bearing tissues in vertebrates. This polymeric 
protein is produced from a ~70 kDa precursor, tropoelastin, During the post-translational modification, a 
network of inter- and intramolecular covalent crosslinks is formed from lysine residues. As many as 
eleven different bi-, tri-, and tetrafunctional modifications are present in mature elastin, which are critical 
for normal tissue function. These products have only been characterized in hydrolysates and 
enzymatically-cleaved peptides, but never observed directly in the intact protein. 
 
Two isotopes of lysine, [U-13C,15N-Lys] and [13Cε-Lys], were independently incorporated into the neonatal 
rat smooth muscle cell (NRSMC) elastin. Samples with high levels of enrichment (~90%) were used for 
high-resolution solid-state nuclear magnetic resonance (ssNMR) studies. One- and two-dimensional 
measurements allowed for analysis of the secondary structures of lysines. Random coil and α-helices 
were the predominant conformations. The helical content is higher in a frozen sample than at the 
physiological temperature. Experiments based on cross-polarization allowed for quantification of 
unmodified lysine as well as desmosine and isodesmosine, crosslinks unique to elastin. The presence of 
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Elastin is a protein found in the extracellular matrix of all vertebrates except primitive cyclostomes. It gives 
elasticity and resilience to blood vessels, skin, lungs, aorta, ligaments, and many more, as it is found in 
almost every organ. This protein undergoes billions of stretch-recoil cycles without significant turnover.1 In 
fact, the elastic fiber is normally a metabolically stable unit over the human lifespan.2 
 
Elastin is a polymeric protein stabilized through covalent crosslinks derived from lysine (Lys). These post-
translational modifications differentiate mature elastin from its soluble precursor, tropoelastin (TE). The 
amino acid composition of the TE monomer varies, depending on the species. However, it generally 
consists of about 800 residues, with glycine (Gly), alanine (Ala), proline (Pro), and valine (Val) being the 
main constituents.3  
 
1.2 Elasticity models 
Up to this day, both the mechanism of elasticity and the three-dimensional structure of elastin remain 
unclear. The extensive network of crosslinks makes elastin insoluble in common solvents. Therefore, 
solution nuclear magnetic resolution (NMR) spectroscopy cannot be used to resolve the structure of the 
mature protein. In addition, elastin does not crystallize, which excludes X-ray crystallography from the 
pool of available characterization methods. The postulated models of elasticity are based on the limited 




In the network model (figure 1a), elastin is considered to be a rubber-like elastomer; the chains are 
permanently crosslinked but remain kinetically free.4 Entropy is assumed to drive the recoil after 
stretching. This model agrees with some early studies.5,6 However, unlike rubbers, elastin is not self-
lubricating and has the elastic properties only when swollen in water.7 In addition, the network model does 
not account for the coacervation of elastin8, that is, the process of monomer self-association during the 
elastic fiber assembly.9 This phenomenon occurs in solutions of TE heated to 37°C and results in the 
proper alignment of monomers for crosslink formation.3 
 
 
Figure 1.1: Models of elasticity.  
a) Network model,4 (b) liquid drop model,10 (c) oiled coil model,11 (d) fibrillar model.12 Figures are 





The liquid drop (figure 1.1b)10 and oiled coil (figure 1.1c)11 are similar models; they assume stretching 
exposes the hydrophobic domains of elastin to the solvent. As a result, the entropy of the system 
decreases. In the liquid drop model10, monomers form globules with hydrophilic surfaces and hydrophobic 
interiors. In the other model11, the hydrophobic Pro and Val residues are inside of the ‘oiled coil’, which 
alternates with α-helical crosslinking domains. Both models were rejected due to high mobility of the 
hydrophobic regions confirmed by optical spectroscopies13 and 13C NMR studies.14 
 
In the fibrillar model (figure 1.1d), hydrophobic domains form β-spirals that alternate with ɑ-helical 
crosslinking domains.12 The chains are additionally held together by hydrophobic interactions. The 
segments between the β-turns are dynamic and undergo librations, i.e., low-amplitude and high-
frequency rocking motions. Stretching of the protein lowers the amplitude of those librations, introducing 
more order. Therefore, entropy drives the recoil. This model was rejected due to inconsistency with 
circular dichroism (CD)15 and molecular dynamics (MD) simulations.16 The experimental data suggest β-
spirals are not found in the structure of elastin15, whereas computational studies support the hydrophobic 
(rather than librational) mechanism of elasticity.16 
 
Tamburro et. al. developed a conformational ensemble model that assumes an equilibrium between 
polyproline II helix (PPII), β-turns, and unordered coils (figure 1.2).17 Each of these conformations has its 
own, additional internal fluctuations. Stretching shifts the conformational equilibria from folded to 
extended structures. The recoil is driven by high entropy of the protein in the relaxed state. 
 
Figure 1.2: Tamburro conformational ensemble model.17 
Polyproline II helix (PPII), β-turns, and unordered coil structures are in equilibrium. Figure reproduced 





The conformational ensemble model was based on NMR and CD studies of peptides encoded by 
individual exons of TE (figure 1.3), rather than the complete protein. The organization of elastin has been 
postulated to have fractal properties, i.e., to have repeating sequences found at different scales in the 
structure.18,19 In Tamburro’s analysis, each exon corresponds to a self-contained structure that has a 
distinct function and is autonomous of the other parts of the protein. This premise is supported by 
coacervation of the domains encoded by exons 18, 20, and 24 (EX18, EX20, EX24) in a similar way to 




Figure 1.3: Organization of tropoelastin gene based on the cDNA structure.20 
Figure adapted from Tamburro et. al.17 Exon 1 is the signaling sequence. Exon 36 is a hydrophilic peptide 
responsible for interaction with other elastic fiber proteins. Hydrophobic domains are represented with 
rectangles. Crosslinking domains are indicated with dark blue (alanine-rich) and light blue (proline-rich) 
hexagons. 
 
1.3 Biosynthesis of elastin 
The biosynthesis of elastin starts with the conversion of Lys residues in TE to allysine (Lya), a reactive 
aldehyde (figure 1.4A).21 This oxidative deamination of the ε-amino group of Lys is performed by lysyl 
oxidase (LOX).22 Lya then reacts further by nonenzymatic condensation to form allysine aldol (AA) via 
aldol condensation with another Lya23, or dehydrolysinonorleucine (DLNL) through a Schiff base reaction 
with Lys.24 DLNL, similarly to dehydromerodesmosine (DMDES), serves as both an intermediate for more 
complex structures and an independent crosslink. In the latter case, DLNL and DMDES are eventually 
reduced to lysinonorleucine (LNL)25 and merodesmosine (MDES)26, respectively. Some crosslinks have 
been reported in the literature less frequently and have not been quantified (figure 1.4B). Allodesmosine 
(ADES)27, cyclopentenosine (CPN)28, and pentasine (PEN)29 are products of alternative reactions of Lya 





Figure 1.4: Post-translational modification of lysine and the resulting crosslinks.31 
The synthesis of the most common crosslinks (A) and the less frequently reported species (B) are shown. 
Colored circles indicate 13C originating from 13Cε in [ε-13C-Lys]: aliphatic (pink, purple), heteroaromatic 
(green), and carbonyl (blue). 
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1.4 Crosslinking in health and disease 
Elastin’s crosslinks play an important role in the health and disease of mammalian connective tissue. 
Undercrosslinked elastin does not have the properties of elasticity and resilience. Pigs deprived of 
copper, an essential cofactor to LOX, suffer from impaired crosslink synthesis, resulting in ruptures of 
major vessels.32 Similar effects are observed in the genetic disorders of elastin. In Menkes disease, 
incomplete crosslinking occurs due to compromised absorption of copper. High mortality is observed 
among patients, most of whom do not live past the age of 3.33 X-linked cutis laxa, on the other hand, is 
caused by defects in LOX itself. The prognosis depends on the severity of elastin impairment. If skin is 
the only affected tissue, life expectancy is normal. However, if the internal organs are impaired and 
pulmonary damage is present, the prognosis is poor.34 
 
Diseases associated with the pathology of elastin are also acquired. Smoking tobacco and air pollution 
cause chronic obstructive pulmonary disease (COPD). This disorder is associated with lower 
concentrations of the two crosslinks unique to elastin, desmosine (DES) and isodesmosine (IDES), in the 
alveolar tissue.35,36 As a result of elastolytic proteases degrading the elastic fibers, patients with COPD 
have higher concentrations of these two amino acids in their blood and urine. A sensitive analytical 
technique allowing for the detection of DES and IDES is needed for diagnostic and prognostic purposes.37 
 
Degradation of elastin is also related to aging processes. The rapid synthesis rates in young animals 
decrease with age, and this protein is characterized by a slow turnover. Both the amount of elastin and 
the quantity of crosslinks in elastin are lower in tissues collected from older animals.38,39 In a study of 
human aortas, the quantity of nearly every kind of crosslink was lower in the samples collected from older 
subjects. Interestingly, the ratio of NDES to the sum of DES and IDES showed a positive correlation with 
age after adolescence. The weakening of the elastic fibers is attributed to this relative increase in the 
NDES content.40  
 
1.5 Quantification of crosslinks 
Crosslinks have been isolated, characterized, and quantified by multiple research groups.24,41,42,43 
However, these lysine-derivatives have never been observed in native, intact elastin. Since this protein is 
relatively stable, strong acids and bases, as well as high temperature and pressure, were often used in 
extraction and purification procedures.44 Moreover, crosslinks are typically isolated from hydrolysates, 





The quantities of crosslinks reported for a single sample of elastin depend on the purification protocol 
used (table 1.1).21 Harsh conditions affect the number of crosslinks and yield a more fragmented protein. 
Thus, the isolated elastin may not resemble the one found in vivo.46 Values for AA are the most reliable, 
varying only by 5%. Discrepancies for tetrafunctional crosslinks, DES and IDES, are about 15%. LNL has 
the least reproducible results, differing by over 50%. Furthermore, each of the compared approaches 
accounts only for 25 – 29 out of the 38 lysine equivalents in BLN elastin.47  
 
 
Table 1.1: Quantities of crosslinks in BLN elastin after different purification protocols.21  




Alkali Autoclaved Collagenase Formic Acid 
IDES 4.24 4.36 4.24 3.56 
DES 5.48 5.20 5.16 4.60 
DMDES 2.73 2.37 2.55 2.43 
MDES 0.66 0.78 0.66 0.69 
DLNL 0.20 0.14 0.30 0.50 
LNL 2.28 1.66 1.38 1.22 
AA 5.84 5.52 5.80 5.86 
Lys (unmodified) 6.10 7.00 8.50 5.90 
Lys equivalents (sum) 27.53 27.03 28.59 24.76 
 
 
1.6 Crosslinking sites 
High-resolution mass spectrometry (MS) data provide information on positions and patterns of 
crosslinking in elastin (figure 1.5).43 Both KP and KA domains contain some unmodified Lys. KP domains 
are almost exclusively crosslinked by LNL, whereas KA domains are linked by LNL, AA, DES, and IDES. 
About half of the bifunctional crosslinks do not undergo further condensation due to steric hindrance. 
Similarly, Lys residues followed by bulky amino acids (leucine, isoleucine, phenylalanine, or tyrosine) 
remain unmodified, as LOX cannot access them. A large number of intramolecular crosslinks between 
Lys residues in close proximity was found. Overall, elastin is heterogeneously crosslinked; i.e., two 
domains are not always connected with each other. Similarly, a Lys residue within the TE sequence may 






Figure 1.5: Crosslinking sites in elastin.  
Figure reproduced from Schmeltzer et. al.43 Gray boxes represent hydrophobic domains. Hydrophilic 
domains with KP and KA motifs are shown in red and blue, respectively. The width of the boxes 
corresponds to the relative length of the domains. Numbering corresponds to exon assignment. For 
clarity, all links are shown as intramolecular crosslinks.  
 
 
The high-resolution MS data provide important information about the organization of elastin, but this 
approach has limitations. For example, no residues of highly reactive Lya were detected. Elastin was 
enzymatically cleaved, and soluble peptides were studied rather than the intact protein. To understand 
crosslinking in native elastin as well as secondary structures and dynamics, a complementary analytical 




1.7 Solid-state NMR  
NMR is a powerful method that has been widely used to characterize the structure and dynamics of 
biomolecules. Only soluble samples that are available at sufficient concentrations can benefit from 
solution NMR studies. Solid-state NMR (ssNMR) does not have as many limitations. Because crystalline 
structure is not required, this technique allows for studies of amorphous proteins that are inaccessible to 
X-ray diffraction.  
 
Biological samples are commonly characterized with NMR measurements of spin-1/2 nuclei, such as 1H 
and 13C. 1H nuclei offer high natural abundance and sensitivity (table 1.2). However, only relatively small 
molecules allow for sufficient resolution in the 0 – 12 ppm chemical shift range of 1H. The spectral range 
of 13C is greater (0 – 200 ppm), and the 13C chemical shift can identify secondary structures in the protein 
backbone.48 However, sensitivity is only a quarter of that of 1H, and the natural abundance of 13C is very 
low (1.1%). Selective isotopic enrichment is often necessary to observe the targeted signals. The 15N 
nucleus is even more problematic, as very low natural abundance is accompanied by poor sensitivity. 
Even with isotopic enrichment, detection of rare residues may not be possible. 
 
 
Table 1.2: Natural abundance levels and relative sensitivities based on gyromagnetic ratios (γ/γH) 
of common nuclei.49 
Nucleus Natural Abundance (%) Relative Sensitivity 
1H 100.00 100 
13C 1.10 25 
15N 0.37 10 
 
 
SsNMR spectra are characterized by broad signals resulting from chemical shift anisotropies (CSA) and 
dipolar couplings. The external magnetic field, B0, affects the electrons surrounding the nucleus, which 
produce small magnetic fields. These fields either add or subtract from the magnetic field experienced by 
the nucleus. Electron clouds are rarely symmetrically distributed. Therefore, the effects of the electron 
density on the resonance frequency are orientation-dependent. Similarly, the interactions of nuclear 
magnetic moments of different spins, i.e., heteronuclear dipolar couplings, also depend on orientation. In 
solution, molecular tumbling averages the effects of CSA and dipolar couplings, but such rapid motions 
are not present in solids. Magic Angle Spinning (MAS) is applied to reduce the orientation-dependent 




Figure 1.6: Spinning a rotor with a sample at a magic angle. 
 
 
MAS refers to the spinning of the rotor containing a sample at 54.74° relative to the external magnetic 
field B0. The mechanical spinning results in averaging of the internuclear interactions, reducing the effects 
of CSA and dipolar couplings. If the spinning rate is smaller than the magnitude of anisotropy, spinning 
sidebands are observed at the multiples of the spinning speed. Spinning sidebands may introduce 
ambiguity in assignments, especially in spectra of large molecules. 
 
Direct Polarization (DP) is an excitation scheme traditionally used for solution 1H NMR of organic 
compounds. However, 13C DP has been used to characterize elastin.50,51 This excitation scheme provides 
quantitative NMR spectra, i.e., with peak areas proportional to the number of 13C spins. In this single-
pulse measurement, a 90° pulse is applied on the 13C channel. An acquisition period follows with high-










Figure 1.7: Pulse sequences for (A) 13C DP and (B) 13C CP experiments. 
Black rectangle represents a 90° pulse. 
 
 
The main drawback of the DP measurement is the long experimental time needed for acceptable signal-
to-noise ratios (S/N) in the spectra of biological solids. The recycle delay, or time needed for recovery of 
the equilibrium magnetization after each scan, depends on the spin-lattice relaxation time constant (T1C), 
which tends to have large values in biological solids. To obtain >99% recovery, the recycle delay needs to 




Cross Polarization Magic Angle Spinning (CPMAS) is a common ssNMR experiment that has better S/N 
than DP in a given time period.52 In this measurement, a 90° 1H pulse rotates the magnetization to the 
transverse plane, which is then spin-locked using continuous radio-frequency (rf) irradiation, B1H (figure 
1.7B). At the same time, an rf field, B1C, is applied on the 13C channel, such that the Hartmann-Hahn (HH) 
condition53 is met: 
 
=  + 𝑛        (Equation 1.1) 
 
where   is a spinning rate of the rotor, and n = 0, ± 1, ± 2.  
 
The dipolar-coupling-mediated transfer of magnetization from 1H to 13C spins follows the 1H 90° pulse. 
This process results in an enhancement of signal intensity (compared to DP), which is proportional to the 
differences in the gyromagnetic ratios = 4 .49 Since the carbon excitation arises entirely from the 
contact with protons, the T1H constant determines the delay between successive scans rather than T1C. 1H 
T1  relaxation times are shorter than those of 13C, decreasing the experimental time.  
 
If spinning sidebands are observed in a CP/MAS spectrum, Total Sideband Suppression (TOSS) 
sequence can declutter a complex spectrum without altering the spinning rate.54 Without TOSS, the 
amplitudes and phases of the sideband components are dispersed, due to different orientations of spins. 
After the four 180° 13C pulses (figure 1.8) of TOSS, the phases become evenly distributed in the complex 
plane, i.e., cancelled when averaged.55 The periodic variation at the spinning frequency is eliminated, 
resulting in spectra without spinning sidebands. 
Figure 1.8: Pulse sequence for 13C CP TOSS experiment.54 
Black and white rectangles represent 90° and 180° pulses, respectively. TOSS delays, t1, t2, t3, t4, and t5, 
separate 13C 180° pulses. 
13 
 
1.8 Scope of thesis 
This thesis presents studies of lysine and lysine-derived crosslinks in mature, intact elastin via ssNMR 
spectroscopy. Two isotopes, [U-13C,15N-Lys] and [13Cε-Lys], were independently incorporated into the 
neonatal rat smooth muscle cell (NRSMC) elastin. Secondary structures are assigned, based on one- and 
two- dimensional experiments. The dynamics was probed by spin-lattice relaxation measurements. 
Modified cross-polarization excitation schemes allowed for detection and characterization of crosslinks in 
the intact protein. Quantities of unmodified lysine as well as desmosine and isodesmosine were 
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CHAPTER 2  
ISOTOPIC ENRICHMENT OF LYSINES IN 
ELASTIN 
 
2.1 Isotopic enrichment via the neonatal rat smooth muscle cell (NRSMC) 
line 
Selective labeling of amino acid increases the intensity of targeted signals. The NMR-active 13C nuclei 
has low natural abundance, constituting only 1.1% of carbons in unenriched samples.1 Moreover, lysine is 
a minor component of elastin. Without isotopic enrichment, the sensitivity and resolution are insufficient 
for NMR studies. Signals of rare crosslinks are not observed at all, and unmodified lysines are 
indistinguishable from the rest of the protein. 
 
The ideal elastin expression system achieves high isotopic enrichment, allows for easy manipulation of 
the conditions, and does not raise ethical concerns. In the early days of the elastin research, 13C nuclei 
were introduced to samples by incubation of tissues in labeled media.2,3 The produced elastin carried the 
label in only 20% of its lysine, 10% of valine, and 6% of alanine residues. This approach required large 
quantities of the expensive isotope and substantial sacrifice of vertebrates. Thus, modern NMR studies 
rely on expression through cell cultures. 
 
Labeled elastin-like peptides4,5 and a recombinant human tropoelastin6 have been prepared with bacterial 
hosts, but this method is not well-suited for studies of lysine and crosslinks. Lysine is an essential amino 
acid in animals, but it is synthesized de novo in bacteria.7 Direct substitution, i.e., supplementing the cell 
culture media with labeled lysine, would not result in high enrichment of elastin in bacterial hosts. 
Unenriched lysine is still synthesized by E. coli, diluting the labeled residues. Moreover, prokaryotes lack 
the enzymes for the post-translational modification of tropoelastin. Therefore, treatment of the bacterial 
expression product with chemical crosslinkers would be needed, and the resulting crosslinks would differ 




The neonatal rat smooth muscle cell (NRSMC) line allows for production of large quantities of labeled, 
native-like elastin in a short amount of time. Mammalian expression systems are equipped with the lysyl 
oxidases needed for crosslinking. The protein obtained from NRSMC culture has the same profile as the 
one extracted from a rat aorta in vivo, as confirmed by electron microscopy and amino acid analysis.9 
Sufficient quantities for ssNMR spectroscopy are obtained within 6 to 8 weeks.10 
 
High incorporation of labeled glycine, alanine, proline, and valine into elastin have been achieved with the 
NRSMC line.10,11,12 For essential amino acids, direct substitution results in enrichment above 80%. If a 
nonessential amino acid is labeled, this well-understood system allows for manipulation of the conditions. 
For example, improvement of incorporation levels has been achieved by inhibition of in-cell synthesis of 
alanine.12 The NRSMC line is a well-established protocol, suitable for ssNMR studies of lysine and 
crosslinks in elastin. 
 
2.2 Targeting lysine and crosslinks 
This thesis explores two labeling schemes of elastin. [U-13C,15N-Lys] elastin is grown in media with 
uniformly-13C- and -15N-enriched lysine (figure 2.1A). Separately, the medium is supplemented with lysine 
that has a single 13C label at the epsilon () position to obtain [ε-13C-Lys] elastin (figure 2.1B). The NMR-
active nuclei are also incorporated into the numerous crosslinks that are derived from this amino acid 








Figure 2.1: Structures of enriched lysine.   
















Different types of covalent crosslinks are present in mature elastin (figure 2.2). During elastogenesis, the 
lysyl oxidase (LOX) enzyme converts a lysine residue in tropoelastin to a reactive allysine (Lya), which 
further reacts to form bi-, tri-, and tetrafunctional crosslinks.13 The most abundant modification products 
are desmosine (DES) and isodesmosine (IDES).14 Allysine aldol (AA) and lysinonorleucine (LNL) are also 
commonly reported, but unlike DES and IDES, they are not unique to elastin.15 The details of the 




Figure 2.2. Structures of the lysine-derived crosslinks in elastin. 
NRSMC cultures grown in media with U-13C,15N-Lys have 13C and 15N labels at all carbon and nitrogen 





[U-13C,15N-Lys] elastin has the NMR-active isotope at all carbon and nitrogen atoms in the pictured 
crosslinks (figure 2.2). Thus, they have correspondingly higher molecular weights (MW) than their 
counterparts in the unenriched protein. For example, enriched Lya, the smallest of the modification 
products, is 8 g/mol heavier than its unlabeled equivalent. The difference in MW of labeled and unlabeled 
tetrafunctional crosslinks, DES and IDES, is 29 g/mol. 
 
The mechanisms of crosslink formation determine the label-bearing sites in [ε-13C-Lys] elastin. With the 
exception of neodesmosine (NDES), the number of lysine equivalents corresponding to each crosslinking 
moiety is the same as the increase of the molecular weight. Therefore, the difference in the molecular 
weight of even the largest pentafunctional species, such as the rare pentasine (PEN) or allodesmosine 
(ADES), does not exceed 5 g/mol.  
 
Neodesmosine appears to be a trifunctional crosslink, which would correspond to three lysine 
equivalents. However, in the [ε-13C-Lys] elastin sample, the expected increase in the molecular weight is 
4 g/mol rather than 3 g/mol. Unlike other crosslinks, NDES is formed during the decomposition of DES 
and IDES, rather than synthesis from three lysine equivalents (figure 2.3). The bond between Cδ and Cε 
in DES or IDES is broken, and the Cε remains in the pyridinium ring. The exact details of the reaction 
mechanism have not been elucidated, but this process is associated with aging. Studies of human aortas 
showed a gradual increase of the   ratio with age.16  
 
Figure 2.3. Formation of neodesmosine from partial decomposition of desmosine. 
Circles indicate 13Cε in [ε-13C-Lys] elastin. The green circle is a remnant of the fourth lysine equivalent 





2.3 Metabolism of enriched lysine 
Incorporation of an enriched, essential amino acid, such as lysine, into a protein is straightforward. Since 
the targeted residue cannot be synthesized within the cells from other molecules, direct supplementation 
is sufficient, without other manipulation of the metabolic pathways. The desired isotope is added to lysine-
free cell culture media, serving as the only source of this amino acid. As the labeled lysines undergo post-
translational modification, the NMR-active nuclei are incorporated into the resulting crosslinks. 
 
For the targeted enrichment to be effective, it is crucial that the isotopic labels are introduced only at the 
desired sites. If an enriched residue is a precursor for synthesis of other amino acids, the NMR-active 
nuclei are passed to other locations in the protein. This process is known as scrambling. The possible 
destinations of the labels in enriched lysine are predicted, based on the metabolic pathways.  
 
In mammalian cells, lysine is catabolized through saccharopine or pipecolic acid intermediate (figure 
2.4).17 These two routes converge into a common degradative pathway once the allysine intermediate 
(Lya) is formed. In the steps that follow, carbon dioxide (originating from CO- and Cε-Lys) and two 
molecules of acetyl CoA (one from Cα-, Cβ-Lys and one from Cδ-, Cγ-Lys) are produced. Therefore, 
catabolism of both [ε-13C-Lys] and [U-13C,15N-Lys] produces 13CO2, but only the uniformly labeled lysine 








Figure 2.4: Catabolic pathway of lysine.18 
Structures of the most significant intermediates are shown. Allysine is formed via pipecolic acid pathway 
(dashed arrows) or saccharopine pathway (solid line). Once it is produced, there is a single pathway of 
decomposition. CO and Cε are lost as CO2 molecules. The resulting two molecules of acetyl CoA are 
derived from Cα, Cβ and Cδ, Cγ, respectively. 
 
 
Acetyl CoA enters the Krebs cycle and serves as a precursor to three amino acids present in elastin: 
glutamine (Gln), aspartate (Asp), and arginine (Arg) (figure 2.5). The tropoelastin (TE) sequence only 
contains trace amounts of these residues (< 1.1%). However, if scrambling is substantial, it could still be 
observed in the NMR data. For comparison, lysine constitutes 4.5% of the TE monomer before 








Figure 2.5: Scrambling pathways in the Krebs and urea cycles.4 
Aspartate, glutamate, arginine, and CO2 are emphasized with bold font and frames, as they could lead to 
scrambling in elastin. Carbon dioxide is a precursor to glycine. 
 
 
Carbon dioxide is produced in several steps of lysine catabolism and leads to scrambling to glycine (Gly). 
Both [ε-13C-Lys] and [U-13C,15N-Lys] release 13CO2 originating from 13Cε when glutaconyl CoA is 
degraded to crotonyl CoA (figure 2.4). In addition, the breakdown of [U-13C,15N-Lys] produces three more 
molecules of 13CO2; one from lysine carbonyl, released when α-ketoadipate is converted to glutaryl CoA 
(figure 2.4), and two more in the Krebs cycle (figure 2.5). Gly is the most abundant amino acid of elastin 
(37.2% of TE monomer); hence even minor enrichment of this residue is observed in the spectroscopic 




Figure 2.6: Biosynthesis of glycine and serine from carbon dioxide. 
Carbon from CO2 gas (purple) becomes the carbonyl of glycine and later the carbonyl of serine. 
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Preliminary analysis of the various pathways in the metabolism of lysine and other amino acids provides a 
short list of targets for the HPLC-MS assay. These theoretical and experimental approaches complement 
each other, ensuring viability and accuracy of the labeling protocol. High isotopic enrichment of lysine and 
the crosslinks is anticipated. Low levels of enrichment at 13CO-Gly are also expected. The HPLC-MS 
assay will confirm whether these moieties are labeled and will provide a quantitative measure of the 
enrichment levels. 
 
2.4 Enrichment evaluation via Marfey’s chemistry 
The objective of the assay is quantification of the enrichment at the lysines and the crosslinks as well as 
other residues. High incorporation of labeled lysine via direct substitution is expected, given this amino 
acid is essential. Therefore, enrichment levels of crosslinks formed in the post-translational modification of 
Lys are also expected to be substantial. The catabolism products of Lys serve as substrates for synthesis 
of other amino acids. If any scrambling occurred at Gly, Ser, or other residues, the enrichment needs to 
be quantified for an accurate analysis of the NMR spectra.  
 
The enrichment assay is based on the Marfey’s method, a protocol that has been widely used in the 
analysis of protein hydrolysate composition.19,20,21,22 In this approach, amino acids are derivatized with 1-
fluoro-2,4-dinitrophenyl-5-L-alanine amide (FDAA). The derivatization procedure is simple and 
inexpensive. The products are stable for up to a week in ambient temperatures, if protected from light. 
Sufficient resolution of amino acid derivatives is achieved using a common octadecyl carbon chain (C18) 
column, with acetonitrile-phosphate buffer as a mobile phase and UV detection.20 
 
To determine isotopic enrichment with Marfey’s chemistry, HPLC is combined with mass spectroscopy 
(MS). This setup is referred to as the advanced Marfey’s method.23 Minor modifications of the original 
protocol include replacement of the mobile phase with volatile acetonitrile-tetrafluoroacetic acid (TFA). In 
addition, to improve sensitivity of electrospray ionization (ESI), amino acids are derivatized with 2,4-

















Figure 2.7: The derivatization reagents of the original and advanced Marfey’s method. 
FDAA is known as the Marfey’s reagent. FDLA is its analog used in the enrichment assay for elastin. 
 
 
The elastin samples are hydrolyzed, and the reaction with FDLA in mild alkaline conditions follows (10 
min, 85°C). The free amine group on an amino acid reacts via nucleophilic substitution with the aromatic 
fluorine of FDLA (figure 2.8). If more than one amine is present, as in lysine or desmosine, multiple 
substitutions (and products) are possible. The derivatized amino acids are separated on a reverse-phase 
column. The retention times depend on the hydrophobicity of the species. The more hydrophobic 
derivatives interact more strongly with the C18 column, resulting in longer elution times.  
 
 
Figure 2.8: Reaction between FDLA and an amino acid. 
All available amine groups react with the aromatic fluorine.  
 
 
The relative abundances of the isotopically enriched (Ab[MH + n] +) and unlabeled (Ab[MH]+) amino acids  
were used to quantify enrichment (%) in each residue, where n is the number of labeled nuclei in each 
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The analysis of crosslinks with multiple incorporation sites is complex. For example, n = 29 for desmosine 
in the [U-13C,15N-Lys] elastin sample. Fully enriched desmosine does not exist in nature (Ab[MH + 29]+ = 
0), therefore Rc = 0, as 
 








If a sample is highly enriched, it is likely the molecular ion of the unenriched DES ([MH]+) will not be 










In highly enriched elastin samples, the denominator of Re, Ab[MH]+, is zero for DES and the enrichment 
(%) cannot be determined. 
 
2.5 Materials and methods 
This section provides the detailed procedure for the preparation of elastin samples through NRSMC 
culture, introduction of isotopically labeled lysine, and the evaluation of the isotope incorporation. The 
detailed descriptions of the standard growth media for unlabeled samples, and lysine-free media for 
isotopic labeling is found in Appendix I. 
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2.5.1 Preparation of elastin with isotopically enriched lysine via NRSMC cultures 
Labeled and unlabeled elastin samples were prepared from cultures of NRSMC. Previous reports provide 
details of the extraction of these cells from neonatal rats and the preparation for long-term storage in 
liquid nitrogen.10,27,28 
 
The frozen pellet of NRSMC was quickly thawed in a 37°C water bath and then resuspended in 10 mL of 
standard culture media at 37°C in a T-75 flask. The flask was incubated overnight at 5% CO2 and 37°C to 
imitate physiological conditions. The media was replaced with 20 mL of standard culture media the next 
day and every other day thereafter (i.e., day 3 and day 5). After 7 days, the cells were 90% confluent. At 
that point, the cells were washed twice, each time with 10 mL of 1 x PBS solution. Two mL of trypsin were 
added and the flask was incubated for 5 - 6 min at 37°C. Four mL of standard culture media were added 
to deactivate trypsin. The resulting suspension was spun in a centrifuge (Thermo Electron Corporation, 
Waltham, MA) at 1000 rpm for 10 min. The supernatant was aspirated, and the pellet was resuspended in 
3 mL of standard culture media. One mL of this suspension was added to each T-75 flask, which was 
filled with 9 mL of standard culture media at 37°C. This procedure results in three seeded T-75 flasks. 
Two of these flasks were used to grow [U-13C,15N-Lys] elastin, and the third one was used for unlabeled 
elastin sample (figure 2.9, yellow background). The entire procedure was repeated to obtain two flasks for 







Figure 2.9: Preparation of elastin samples. 
Preparation of [U-13C,15N-Lys] elastin (yellow background) and [ε-13C-Lys] elastin (pink background). Two 
labeled and one unlabeled elastin sample was prepared for each labeling scheme. After a 7-day 
preparatory period, NRSMC were passed to three T-75 flasks (Day 1). The isotope was introduced to 2 
out of 3 cell flasks (Flask 3 is control, natural-abundance) on Day 10. This supplementation continued 
until extraction on Day 56.  
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Elastin is synthesized at the highest rate when cells reach confluency, which occurred on Day 10 of the 
incubation. At this point, the labeled amino acids were introduced to the two out of the three flask. DMEM 
stock without lysine, glucose, arginine, glutamine, and phenol red (Gibco, New York, NY) was purchased. 
Before preparing the cell culture media, the commercial formulation was supplemented with D-glucose 
(1.000 g/L), L-arginine • HCl (0.084 g/L), L-glutamine (0.584 g/L), and phenol red • Na (0.11 g/L). L-Lys • 
HCl was supplemented to the control flask intended for growth of unlabeled elastin at a concentration of 
0.146 g/L. [U-13C,15N, 99%] and [ε-13C, 99%] lysine (Cambridge Isotope Laboratories, Tewksbury, MA) 
were used for the labeled flasks in the respective labeling schemes. [U-13C,15N-Lys] • 2 HCl was 
supplemented at a concentration of 0.181 g/L. The concentration of [ε-13C-Lys] • 2 HCl was 0.175 g/L. 
Details of the custom media formulation and supplementation are provided in Appendix I. 
 
The incubation was continued until the cultures reached Day 56 (or 8 weeks). After that time, the ECM 
layer was scraped from the three flasks and transferred to three Falcon tubes. The elastin samples were 
then purified using the cyanogen bromide (CNBr) method.29 Briefly, 20 mL of CNBr solution (50 mg/mL in 
70% formic acid) were added to each Falcon tube containing the collected cell matrix. The tubes were 
capped and left in a shaker overnight. Then, 12 mL of water were added to each tube. The mixtures were 
left uncapped in a hood for 4 hours to allow evaporation of any remaining toxic HCN. The tubes were 
centrifuged, and the supernatant was disposed. Twenty ml of guanidinium hydrochloride solution (5 M) 
and 0.2 mL of β-mercaptoethanol (1% w/w) were added to each tube and left overnight. A series of five 
centrifugations, each followed by washings with water, was conducted to remove any salts. Purified 
protein was stored in ultrapure water in a refrigerator at 4°C. Each T-75 flask yields 55-60 mg of purified 
elastin after removal of visible water (70-80% w/w) or ~20 mg protein (dry weight). 
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2.5.2 Quantification of isotopic incorporation 
The following procedure was performed in triplicate for [U-13C,15N-Lys] elastin, [ε-13C-Lys] elastin, and the 
control (unenriched) elastin. Approximately 2 mg of elastin are blotted on a KimWipe (Kimberley-Clark, 
Irving, TX) to remove visible water and transferred to a test tube with a lid. One half-mL of H2O and 0.5 
mL of concentrated HCl were added to the sample. The test tube was capped and left in a 100°C oil bath 
for 24 hours. The resulting hydrolysate was transferred to a 10 mL beaker and gently heated to dryness in 
a hood. The residue was then dissolved in 400 μL of an aqueous NaHCO3 solution (84 mg/mL) and 
placed in a test tube with a flea. A bright yellow solution of FDLA in acetone (10 mg/mL) was added in the 
quantity of 200 μL. The biphasic yellow-colorless mixture was agitated until homogenous and then placed 
in an oil bath at 85°C for 5 – 10 min. After the solution cooled to room temperature, three extractions with 
ethyl ether followed. An aliquot of 250 μL of the purified aqueous solution was transferred to a 10 mL 
beaker and mixed with 150 μL of 2N HCl solution. Addition of the acid causes the red solution to form a 
yellow precipitate. It was confirmed with pH strips that pH ≈ 5. The precipitate was dissolved in 600 μL of 
acetonitrile, and this solution was run through a 20 μm filter before injection onto the HPLC column.  
 
Each of the following three HPLC standards were prepared for reaction with 200 μL of FDLA solution. The 
derivatization procedure was the same as described for elastin hydrolysates.  
 
(1) A derivatized mixed standard of glycine, alanine, proline, and lysine was used to optimize the 
chromatography conditions, and confirm the retention times. The solution was prepared from 5 
mg of Lys, 19 mg of Gly, 12 mg of Ala, and 9 mg of Pro, which were dissolved in 10 mL of MiliQ 
water. The proportions mimic those naturally occurring in NRSMC elastin. Two hundred twenty 
μL of this standard were used in the derivatization reaction with FDLA. 
  
(2) The second standard was an equimolar mixture of desmosine and isodesmosine (Cat. No. 
MD687, Elastin Products Co., Inc., Owensville, MO). It confirmed the retention times of the 
multiple substitution products obtained in the derivatization of these crosslinks. Five mg of the 
purchased sample were dissolved in 1 mL of water. One hundred seventy-six μL of this standard 
were used in the derivatization reaction with FDLA. 
 
(3) A glutamine (Gln) standard was prepared to confirm its retention time. Gln is a potential site of 
scrambling, and it has similar molecular weight to Lys (MWGln = 146.14 g/mol, MWLys = 146.19 
g/mol). Moreover, both amino acids form mono- and disubstitution products in the reaction with 
FDLA. A 50 μM aqueous Gln solution was prepared, and 220 μL were used in the derivatization 




All high-resolution MS data were acquired using an Agilent 6545 Q-ToF with attached Infinity 1290 
UHPLC (Agilent Technologies, Santa Clara, CA). All MS data was collected using ESI in the positive 
mode. Chromatographic separations for LC-MS analysis were performed using a reverse-phase column 
with a gradient of two solvents: water with 0.1% formic acid as a modifier (mobile phase A) and 
acetonitrile (mobile phase B).  A 2.1 x 50 mm, 1.8 μm Zorbax Eclipse Plus C18 column (Agilent 
Technologies, Santa Clara, CA) was used. One μL of the sample was injected onto the column. The initial 
solvent composition was 85% mobile phase A : 15% mobile phase B. After 0.75 minutes, mobile phase B 
was ramped to 65% over 9 minutes prior to the final wash at 100% mobile phase B. The flow was set to 
0.5 mL/min. Chromatographic entities were identified using Agilent MassHunter Qualitative Analysis 
B.07.00 (Agilent Technologies, Santa Clara, CA).  
 
To evaluate the precision of the approach, and ensure its accuracy, three samples of [ε-13C-Lys] elastin 
are derivatized (E1, E2, E3) (figure 2.10) and then analyzed by LC/MS.  The Re values for E1, E2, E3 are 
then paired with the Rc values of each of the four control (unlabeled) samples (N1, N2, N3, N4) to 
calculate twelve enrichment data points (Equation 2.1). Three of the unlabeled samples (N1-N3) were 
taken from the unenriched protein grown concurrently with [U-13C,15N-Lys] elastin. N4 was obtained from 
the protein that was grown concurrently with [ε-13C-Lys] elastin. The four Rc values were sufficient for the 
quantification; all control samples were consistent with each other and reflected the natural-abundance 
















Figure 2.10: Mathematical analysis of LC-MS data for the [-13C-Lys] elastin. 
Each labeled sample (E1, E2, E3) was paired with each of the four unlabeled ones (N1, N2, N3, N4) to 
calculate a total of 12 enrichment values (enclosed by dashed lines).  
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A statistical analysis for each amino acid is conducted on the resulting data set. To evaluate the 
significance of the calculated enrichment levels, one-sided t-test was performed at the 95% confidence 
interval. If the mean enrichment value failed the significance test, 0.00% was listed for the given amino 





                                                      (Equation 2.2) 
 
Where s is the standard deviation and N is the number of data points. 
 
Five samples of [U-13C,15N-Lys] elastin (20 data points, E1-E5 paired with N1-N4) were used to determine 
its enrichment. Initially, three samples of [U-13C,15N-Lys] elastin (12 data points) yielded a low calculated 
t-value for Gly (table 2.1) and, thus, the results appeared inconclusive. It was predicted that the 
enrichment levels of Gly in the [U-13C,15N-Lys] elastin would exceed or be the same as those in [-13C-
Lys] elastin. Glycine enrichment results from 13CO2 formed in lysine catabolism, and [U-13C,15N-Lys] has 
more pathways leading to the 13CO2 precursor than [-13C-Lys] (figures 2.4 - 2.5). Scrambling to glycine is 
evident in [-13C-Lys] elastin. To verify the results, two additional enriched samples were derivatized and 
included in the analysis. With the data for E1-E5 and N1-N4, the calculated t-value doubled, confirming 
the statistical significance of the obtained enrichment values. 
 
 

















[-13C-Lys] 1.4 12 6.535 1.796 Yes 
[U-13C,15N-Lys] 0.4 12 1.567 1.796 No 




2.6 Challenges specific to lysine enrichment evaluation 
The LC-MS assay for Marfey’s derivatives of elastin with isotopically enriched lysines poses several 
challenges that were not present in the analogous evaluations of glycines11 or alanines12. The unique 
obstacles result from the low lysine content in tropoelastin, the variety of post-translational modification 
products, and multiple products of the FDLA derivatization. Each of the listed issues adds to the overall 
dilution of the crosslinking compounds, and in some cases, pushes the amount below the limits of 
detection for this method. 
2.6.1 Low quantity of lysine and crosslinks in elastin 
Lysine constitutes fewer than 5% of the residues in the tropoelastin monomer. This number is several 
times lower than the content of glycine and alanine, which make up 37% and 20% of the protein (or 311 
and 164 residues), respectively. In contrast, there are only 38 lysines in the 836 residues of the monomer. 
Details of the amino acid sequence and composition of NRSMC tropoelastin are included in Appendix II. 
 
This low number of lysine residues further decreases upon post-translational modification. Tropoelastin is 
a precursor to the mature insoluble elastin, and, once the crosslinks are formed, the content of 
unmodified lysine drops from 38 to 530, corresponding to < 1% of residues in the monomer. To make 
matters even more complicated, modified lysines form twelve different products (figure 2.2), out of which 
eight have been quantified (table 2.2). Variations in the reported quantities are attributed to tissue source, 
age, protein processing, and the experimental approach. The content of each crosslink never exceeds a 




Table 2.2: Quantities of crosslinks in elastin from different tissues. 
 
Crosslink Quantity (Lys equiv. 
per 1000 residues) 
Tissue type 
Allysine 2, 9.5, <1 Rat aorta, 1, 2, 8-15 weeks, respectively31 
Lysinonorleucine 2.2 BLN32 
1.0 – 2.2 BLN (ranging from foetal to 12 years old)33 
2 Pig aorta34 
Dehydrolysinonorleucine 0 - 0.3 BLN (ranging from foetal to 12 years old)33 
Allysine Aldol 4-5 BLN35 
5 - 7 Chick embryo aorta tissue culture35 
1.5 - 3.4 BLN (ranging from foetal to 12 years old)33 
Merodesmosine 0.5 BLN32 
0.2 - 0.3 BLN (ranging from foetal to 12 years old)33 
Dehydromerodesmosine 0.2 BLN32 
0 - 0.9 BLN (ranging from foetal to 12 years old)33 
Desmosine 10.1 BLN32 
0.8 - 1.8 BLN (ranging from foetal to 12 years old)33 
4.4 NRSMC cell culture30 
Isodesmosine 5.4 BLN32 
0.8 - 1.3 BLN (ranging from foetal to 12 years old)33 
2.8 NRSMC cell culture30 
Pentasine Trace BLN36 
Cyclopentasine Not quantified BLN37 
Allodesmosine Not quantified BLN38 




2.6.2 Multiple Marfey’s derivatives 
Lysine and crosslinks each form multiple products in the reaction with the Marfey’s reagent. For example, 
reaction of FDLA with Ala results in a single product with one retention time. In the same reaction with 
Lys, di-substitution (FDLA-Lys-FDLA) and mono-substitution (FDLA-Lys 1 and FDLA-Lys 2) products are 
formed (figure 2.11A). Instead of observing one signal resulting from the five unmodified Lys residues per 
TE monomer, the intensity is split between three peaks (figure 2.11b). The obtained product ratios are not 
reproducible.  
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 Relative abundance of Lys derivatives in MS spectra 
Batch FDLA-Lys 1 FDLA-Lys 2 FDLA-Lys-FDLA Total 
Unenriched 04/2018 1.25 2.75 1.00 5.00 
Unenriched 12/2018 0.75 1.35 2.90 5.00 
 
 
Figure 2.11: FDLA derivatives of lysine. 
A: Products of derivatization of lysine with FDLA. 
B: Relative abundance of each lysine derivative in two batches of unenriched elastin. Total (sum) of 






The problem of multiple Marfey’s derivatives becomes even more complex as the number of lysine 
equivalents in a crosslink increases. In tetrafunctional desmosine, four amine groups are available for 
substitution. Three chromatographically distinct products are formed in the monosubstitution (figure 
2.12a). Di-, tri-, and tetra- substitution takes place as well. The derivatization time was extended from 10 
min to 20 min to maximize the quantity of the tetra-FDLA-(I)DES. However, the results were similar to the 
previous runs. 
 
The HPLC-MS assay is a sensitive method, which resolves the isomers formed in monosubstitution of 
DES (FDLA-D1, FDLA-D2, FDLA-D3) as well as the di- and tri-substitution. Therefore, a total of twelve 
distinct DES derivatization products are formed (figure 2.12b). IDES is present in comparable quantities 
































Figure 2.12: Possible products of the reaction between desmosine and FDLA. 
A: Reaction scheme showing mono-substitution products. FDLA-D1 and FDLA-D1’ are identical, due to 
symmetry of the molecule. 
B: Summary of distinguishable products for desmosine and isodesmosine. 
Number of FDLA 
Substituents 
Number of Distinct Products 
Desmosine Isodesmosine 
0 1 1 
1 3 4 
2 4 6 
3 3 4 
4 1 1 
TOTAL 12 16 
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2.6.3 Multiple isotope incorporation patterns 
Incomplete isotope incorporation into crosslinks results in varied molecular weights. For example, if 90% 
of Lys residues in elastin is enriched, one in every ten residues is unenriched (figure 2.13). Given one 
DES consists of four Lys equivalents, the aforementioned 10 Lys produce 2.5 DES residues. One of 
these crosslinks has a lower molecular weight than the remaining 1.5 molecules, as it incorporated the 
single unenriched Lys residue. The partially enriched crosslinks in both [U-13C,15N-Lys] elastin and [ε-13C-
Lys] elastin are not detected with MS. 
 
Figure 2.13: Example of incomplete isotope incorporation in desmosine in [U-13C,15N-Lys] elastin. 
Bold lines symbolize fragments carrying 13C and 15N labels.  
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Some other, less likely, combinations are possible as well, such as two enriched and two unenriched or 
one enriched and three unenriched Lys equivalents per desmosine molecule. However, even assuming 
only the discussed scenario, the most intense desmosine peak recognized by the MassHunter algorithm 
of the Agilent software will correspond to the molecular weight of only 1.5 fully enriched desmosine 
molecules out of every 2.5 desmosine residues (figure 2.13). The larger the number of Lys equivalents 
per crosslink, the larger the effect of incomplete isotope incorporation will be. 
2.6.4 Synergy of the challenges 
The described challenges (Sections 2.6.1 - 2.6.3) all contribute to detection of multiple signals arising 
from a single amino acid. The challenges produce a synergistic effect. For example, desmosine has 5 
potential incorporation patterns (0 - 4 enriched lysine equivalents in the structure). Given 12 possible 
products of the reaction with FDLA, technically 60 distinct outcomes are possible. Some of these products 
are more prevalent than others, but all of them contribute to dilution, in some cases, resulting in 
concentrations below the detection limits. As a result, the rare crosslinks are not observed at all with MS. 
The detection of the more common DES and IDES is inconsistent. The limitations of the Marfey’s method 
and Wolfe’s equation need to be acknowledged in the analysis of this complex system. 
 
2.7 Results and discussion 
An HPLC-MS assay evaluating enrichment of [U-13C,15N-Lys] and [ε-13C-Lys] elastin was conducted. The 
protein samples were hydrolyzed and then derivatized with FDLA. MS data for these derivatives were 
used to calculate the enrichment (%) of each amino acid. The reported values reflect the percentage of 
the residues that carry a labeled nucleus (13C or 15N), exceeding natural-abundance levels. 
2.7.1 Enrichment of lysine 
High incorporation of labeled lysine into elastin was achieved via direct substitution. The enrichment of 
[U-13C,15N-Lys] elastin was 87.3 ± 0.4% (table 2.3). The calculations for [U-13C,15N-Lys] elastin were 
based on data for FDLA-Lys-FDLA, as the other substitution products, i.e. FDLA-Lys 1 and FDLA-Lys 2, 




The enrichment of lysine in [ε-13C-Lys] elastin was estimated to be ~87%, or equivalent to that of U-
13C,15N-Lys] elastin. NMR data confirm successful incorporation of [ε-13C-Lys] (Chapter 4). The relative 
abundance of the enriched lysine was detected in each run. However, the unenriched lysine was not 
detected in any of the three trials for [ε-13C-Lys] elastin. Therefore, the Wolfe equation was not applicable, 
as Re would have 0 in the denominator (equation 2.1). Both labeling protocols followed the same 
schedule for, e.g., isotope introduction and protein extraction. Thus, the enrichment levels are expected to 
be comparable.  
 
 
Table 2.3: Lysine enrichment in [U-13C,15N-Lys] elastin and [ε-13C-Lys] elastin. 










87.3 ± 0.4 
 
~ 87 (estimated) 7b 
a amino acid analysis of elastin from 8-week long NRSMC cell culture30 
b NMR studies, see Chapter 4 
 
2.7.2 Enrichment of desmosine and isodesmosine 
Desmosine and isodesmosine, hereafter defined as (I)DES, are indistinguishable by MS. The assay 
results for these crosslinks are inconsistent. To calculate enrichment (%), labeled and unlabeled (I)DES 
needs to be detected in a single enriched sample. Only one HPLC-MS run for [U-13C,15N-Lys] elastin met 
this condition (table 2.4). In the other seven trials for enriched elastin (of either labeling scheme), only the 
labeled (I)DES was observed; the unenriched crosslink was not detected. Similarly, not all the unlabeled 













Table 2.4: HPLC-MS results for (I)DES in [U-13C,15N-Lys] elastin. 
Tetra-FDLA-(I)DES refers to desmosine and isodesmosine with all four amino groups substituted with 
FDLA. 






















Wolfe’s equation does not capture the complexity of the tetrafunctional crosslinks. This approach neglects 
the multiple isotopic incorporation patterns, that is, labeled (I)DES which contains at least one unenriched 
lysine equivalent. With 87% enrichment of Lys, partially labeled (I)DES is non-negligible; approximately 1 
out of every 2.5 (I)DES residues is partially labeled (figure 2.13).  
 
Converting the relative abundances to ratios, rather than percentages, is a more informative way of 
interpreting the data. For every unenriched (I)DES (m/z = 1703) there are ~14 fully enriched ones (m/z = 
1732). The HPLC-MS assay did not provide data on partially labeled species. Thus, their exact 
contribution was not determined experimentally. However, following the ratio determined in Section 2.6.3, 
it is estimated that for every 14 fully enriched (I)DES residues (m/z = 1732), there is ~9 partially labeled 
residues (m/z = 1723) (figure 2.13). 
2.7.3 Scrambling to glycine and aspartic acid 
Quantification of the enrichment of 13CO-Gly allows for an accurate interpretation of NMR spectra. 
Enrichment of glycine in [U-13C,15N-Lys] and [ε-13C-Lys] elastin was 0.5 ± 0.2% and 1.4 ± 0.2%, 
respectively (table 2.5). These percentages translate to 1.6 and 4.4 glycine residues per TE monomer. In 
both labeled proteins, the 13CO2 released during decomposition of Lys (figures 2.4 – 2.5) was 
incorporated at the carbonyl position in Gly (figure 2.6).  
 
Scrambling to aspartic acid was confirmed in [U-13C,15N-Lys] elastin. Enrichment of 1.9 ± 0.4% was found. 
Asp is a minor component of elastin (1 residue per 836 in a TE monomer). Therefore, the contribution of 
this enriched amino acid is equivalent to 0.02 residues of 13CO-Asp per monomer. This relatively small 
quantity of 13C is negligible in NMR spectra. No scrambling to [ε-13C-Lys] elastin was observed, which is 
consistent with the predictions based on metabolic pathways. 
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Table 2.5: Scrambling in [U-13C,15N-Lys] elastin and [ε-13C-Lys] elastin. 

















Gly 311 0.5 ± 0.2 1.56 ± 0.62 1.4 ± 0.2 4.35 ± 0.62 
Asp 1 1.9 ± 0.4 0.02 ± 0.01 0.0 0.00 
 
 
The assay detects isotopic enrichment of an amino acid but does not distinguish between 15N and 13C 
incorporation. Both nuclei were introduced to [U-13C,15N-Lys] elastin. However, no metabolic pathway that 
that transfers 15N from Lys to Gly or Asp was identified, whereas such routes exist for 13C (figure 2.5). 
Thus, the enrichment of these two amino acids is attributed to the 13C nuclei. NMR studies are consistent 
with 13CO-Gly scrambling (Chapter 3). 
2.7.4 Results for remaining amino acids 
Glycine, aspartic acid, serine, glutamine, and arginine were predicted sites of scrambling. Enrichment of 
Gly, which serves as a precursor to Ser, was confirmed in both [U-13C,15N-Lys] and [ε-13C-Lys] elastin. 
However, no enrichment of Ser was found. Gln, Arg, and Asp are synthesized from acetyl CoA, a product 
of lysine catabolism, which enters the Krebs cycle (figure 2.5). Scrambling to Asp in the U-13C,15N-Lys] 
elastin was confirmed. However, Gln and Arg were not enriched in [U-13C,15N-Lys] elastin, and neither of 
these three amino acids was enriched in [ε-13C-Lys] elastin. These experimental results agree with the 
predictions based on the metabolic pathways. 
 
2.8 Summary and conclusions 
High incorporation of labeled lysine into elastin (~87%) was achieved with the NRSMC line. This 
expression system produces NMR-scale quantities of native, crosslinked elastin. The direct substitution 
approach was used, i.e., unlabeled lysine was replaced with enriched lysine in the culture media. 




Evaluation of labeled lysines in elastin posed unique challenges. Unlike previously studied amino 
acids10,11,12, Lys is a minor component of this protein. Moreover, its low concentration is decreased by 
post-translational modification, which results in formation of multiple (Lys-derived) crosslinks. These 
products consist of several lysine equivalents, which introduces additional complexity to the studied 
system. A variety of species with different molecular weights is derived from a single crosslink due to 
incomplete substitution with FDLA and partial incorporation of the labeled lysine. Understanding of the 
intricate system of lysine-derived crosslinks is necessary for an accurate interpretation of the HPLC-MS 
data. 
 
The label was successfully passed to desmosine and isodesmosine, but their enrichment (%) could not 
be accurately determined. However, the ratio of fully enriched (I)DES to unenriched (I)DES was found to 
be 14 : 1. The rare bifunctional crosslinks, such as LNL or AA, were not detected by MS, most likely due 
to low concentrations. These modification products are, however, observed in NMR data. Details of the 
quantification of Lys and Lys-derived residues by ssNMR spectroscopy are provided in Chapter 4. 
 
Minor scrambling to 13CO-Gly (< 2%) was detected in both [U-13C,15N-Lys] and [ε-13C-Lys] elastin. 
Considering this amino acid is the main component of elastin, 13CO-Gly is non-negligible in the NMR 
data. In [U-13C,15N-Lys] elastin, 2% enrichment of Asp was found. Only trace quantities of this amino acid 
are present in elastin, therefore 13CO-Asp has no impact on the NMR spectra. No other sites of 
scrambling were identified at 95% confidence interval.  
Highly enriched samples [U-13C,15N-Lys] elastin and [ε-13C-Lys] elastin were obtained for ssNMR studies. 
Advanced Marfey’s method adjusted to the complex system of crosslinks allowed for the assessment of 
enrichment. The determined values are consistent with ssNMR spectra (Chapter 4). Details of 
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SECONDARY STRUCTURES AND DYNAMICS OF 
LYSINE RESIDUES IN ELASTIN 
 
3.1 Introduction 
SsNMR is the only high-resolution technique that provides structural information about elastin. Since this 
protein does not crystallize and does not dissolve in any standard solvent, X-ray diffraction and solution 
NMR studies cannot be performed. This chapter focuses on secondary structures and dynamics in [U-
13C,15N-Lys] elastin, which allows for observation of all the 13C sites originating from lysine. 
 
One- and two-dimensional 13C NMR spectra are compared to the data in the Re-Referenced Protein 
Chemical Shift DataBase (RefDB) to assign secondary structures and evaluate the neighboring residue 
effects (Section 3.3.1 – 3.3.3). The influence of temperature on the conformations of Lys is probed via a 
variable-temperature (VT) ssNMR study (section 3.3.4). The spin-lattice relaxation times, T1, are 
measured with a modified inversion recovery pulse sequence (Section 3.3.5). 
 
3.1.1 Secondary structures and chemical shifts of amino acids 
Determination of the three-dimensional (3D) structures of proteins is a common research objective. Up to 
this date (10/24/2019), spatial arrangements of 157,145 biological macromolecules have been described 
in the Protein Data Bank (PDB).1 Over 131,000 of these structures were elucidated with X-ray diffraction, 
whereas 11,000 were based on NMR data. Elastin is not found in the PDB database, as it cannot be 
studied with traditional approaches. 
 
Proteins have four levels of structure: primary, secondary, tertiary, and quaternary. Primary refers to the 
sequence of amino acids, encoded by DNA, and held together by peptide bonds. Secondary structure is 
defined by the conformation of local segments and depends on the hydrogen-bonding patterns. The final 
result of the folding process, i.e., the 3D shape of the entire protein, is the tertiary structure. Sometimes 
multiple polypeptide chains operate as a single functional unit. Organization of such subunits is described 




The most prevalent secondary structure in proteins is the α-helix. Alanine has the highest known helical 
propensity and, accordingly, a helical penalty of 0.00 kJ/mol (table 3.1). Proline disrupts ɑ-helices, 
because it does not have a protonated nitrogen to donate to a hydrogen bond2; hence it has the highest 
penalty (13.22 kJ/mol). The conformational flexibility of glycine (4.18 kJ/mol) makes the relatively 




Table 3.1: Relative α-helical propensities of amino acids.3 
Helical penalty for alanine is arbitrarily set to 0.00, and the relative helical penalties for the remaining 
amino acids are listed in ascending order. (The role of neighboring residues is neglected.) 
 

























Both sequence and conformation affect the isotropic chemical shifts of an amino acid in a protein. The 
influence of neighboring residues4,5 and secondary structure6 have been investigated with statistical 
analyses of chemical shift databases. The sequence-dependent effects are the most pronounced at 15N 
and 13CO sites of amino acids in proteins.4 In the three-amino-acid sequence, R-1 – Lys – R+1, the 
chemical shifts of 13CO-Lys and 13Cα-Lys are influenced by the residue that follows lysine (R+1).  
 
The data for lysine in different conformations show some resolution (table 3.2), but a definitive 
assignment is not possible based on a single 13C-Lys site. For example, 13Cα-Lys in α-helix (59.11 ppm) 
is well resolved from its counterpart in a β-sheet (55.01 ppm). However, the same site in a random coil 




Table 3.2: 13C chemical shifts of lysine categorized by secondary structure.6 
Averaged values are based on a dataset for 36 distinct proteins with > 6100 amino acids. Standard 
deviation is shown in parentheses. 
 δ (13C) (ppm) 
 α-helix β-sheet random coil 
13CO-Lys 177.79 (2.22) 174.93 (1.25) 176.15 (1.40) 
13Cα-Lys 59.11 (1.19) 55.01 (1.00) 56.40 (1.80) 
13Cβ-Lys 32.31 (1.08) 34.86 (1.79) 32.57 (1.30) 
 
 
Predominant amino acids of elastin, glycine (Gly), alanine (Ala), and proline (Pro), have been isotopically 
labeled and characterized by ssNMR spectroscopy previously.7,8,9,10 Findings for Ala are particularly 
relevant to the conformational analysis of the Lys residues. These two amino acids are found in the 
crosslinking (CL) domains in tandem repeats, such as KAAK or KAAAK. Evidence for α-helical and 
random coil populations was found for Ala residues in the CL domains. No β-sheet conformations were 





Table 3.3: Alanine populations in NRSMC elastin.7 
Table reproduced from Djajamuliadi et. al.7 Ala residues are found in α-helices or random coils. Lys 
residues are emphasized in a bold font. Cross-linking (CL) and hydrophobic (HP) domains are indicated. 











R-1 – A – A 
R-1 – A – Z 
AAA, KAA, AAK CL 
2 random coil R-1 – A – G GAG, AAG, VAG HP 
3 random coil R-1 – A – Z GAV, GAL, AAK HP + CL 
4 random coil R-1 – A – A AAA, KAA, PAA CL 
 
3.1.2 Selection of ssNMR experiments for structural studies of elastin 
To explore different populations of lysine in elastin, various excitation schemes are explored. DP reflects 
all 13C sites, regardless of conformation and dynamics, and is quantitative. CP selectively detects rigid 
regions, and refocused Insensitive Nuclei Enhanced by Polarization Transfer (rINEPT) enhances signals 
from mobile domains. These experiments provide insights into the secondary structures of lysine in rigid 
and mobile sections of the protein. 
 
DP with steady-state Nuclear Overhauser Effect (ssNOE/DP) is used to obtain a higher S/N in a shorter 
experimental time than in DP. SsNOE improves the 13C intensities of protonated carbons by a factor of η, 
according to Equation 3.2. The 13C populations with high mobility are more effectively enhanced by NOE 
than the rigid ones. 
 
1 +  𝜂 =  
 (   )
 (  )
  (Equation 3.1) 
 
In ssNOE/DP, the 1H spin populations are saturated using low-power rf irradiation, before a 90° pulse on 
the 13C channel (figure 3.1). As the high-energy 1H spins return to equilibrium, the z-magnetization is 





Figure 3.1: Pulse sequence for 13C ssNOE/DP experiment. 
Black rectangle represents a 90° pulse. 
 
 
The rINEPT experiment11,12 targets mobile regions of hydrated elastin that undergo “liquid-like” motions 
(figure 3.2).13 The fast internal dynamics of the hydrated protein attenuate the dipolar couplings. Thus, the 
CP excitation scheme, which is based on the 1H-13C dipolar coupling, is not effective in this system. In 
rINEPT measurements, the magnetization transfer efficiency is governed by the coherence lifetime, T2’. 
Mobile systems have longer T2’ values than the rigid ones, resulting in higher efficiency of the rINEPT 
transfer. Only protonated carbons are detected with this experiment, because polarization is transferred 
from 1H to directly bonded 13C nuclei. 
 
In the rINEPT experiment, the initial 90° pulse on the 1H channel creates transverse magnetization. 
Relaxation results in dephasing during the first -delay at a rate of 𝑒 . Thus, after 2, only the 1H 
coherences with long lifetimes survive, i.e., protons in mobile domains, which typically have large-
amplitude oscillations and long T2’ values. A 180° pulse is applied to both spins, and offsets are refocused 
after 2, but the JCH coupling continues to evolve during the entire 2 period. At the end of 2, proton 
magnetization components are anti-phase, and the simultaneous 90° pulses on 1H and 13C channel cause 
a polarization transfer. The final spin-echo sequence (’ - 180° - ’) refocuses the anti-phase 
magnetization, so that broadband decoupling can be applied during acquisition. Since magnetization of 






Figure 3.2: Pulse sequence for 13C-{1H} rINEPT experiment. 
Black and white rectangles represent 90° and 180° pulses, respectively. The phases were as follows: Φ1 
= {x}; Φ2 = {y}. 
 
 
Signal overlap is unavoidable in the 1D NMR of elastin. For example, studies of [ε-13C-Lys] elastin confirm 
a contribution from crosslinked 13Cε in the 13Cα region of the spectrum (Chapter 4). Moreover, scrambling 
to 13CO-Gly is confirmed with the HPLC-MS assay (Chapter 2) and NMR data (Chapter 4). The 13CO-Gly 
intensity is not resolved from 13CO-Lys. These overlapping signals are resolved in a two-dimensional (2D) 
13CO-13Cα-Lys correlation spectrum. 
 
Dipolar Assisted Rotational Resonance (DARR) is a popular method of characterization of solid proteins, 
allowing for 13CO-13Cɑ correlation. This technique is appropriate for samples with adjacent 13C nuclei, 
which allow for 13C spin diffusion. After the initial CP excitation, a selective, r-SNOB shaped14 pulse is 
applied to 13CO with 1H continuous wave (CW) decoupling. Since only 13CO signals are detected in the 
indirect dimension, the spectral window is narrowed to 164 – 184 ppm, which reduces the total 
experimental time. A spectrum is recorded for each increment of t1, until the signal decays. The phase of 
the r-SNOB pulse is alternated between x and y, and the phase of the receiver shifts between x and -x. 
This two-step phase cycling detects t1-modulated signals of 13CO, but not others. A 90° 13C pulse is 
applied, and DARR mixing follows to obtain 13CO-13C correlations. Since the natural abundance of 13C is 
low (~1.1 %), the correlations detected by this pulse sequence originate from 13C - 13C pairs in enriched 
Lys residues only. A final 90° 13C pulse flips the magnetization for detection, and high-power TPPM 





Figure 3.3: Pulse sequence for 2D 13CO-13Cα DARR correlation.15 
Black rectangle represents a 90° pulse. The phase cycling was as follows: Φ1 = {y, y, y, y, -y, -y, -y, -y}; 
Φ2 = {x}; Φ3 = {-y}; Φ4 = {x}8 {y}8; Φ5 = {x}; Φ6 = {x, y, -x, -y}; Φrec = {x, y, -x, -y, -x, -y, x, y, -x, -y, x, y, x, 
y, -x, -y}. 
 
3.1.3 Interpretation of NMR spectra with RefDB data 
Due to a range of solvent conditions, reference standards, and measurement protocols, chemical shifts 
are prone to inconsistent referencing. RefDB is a secondary database developed to address this problem 
by validating and correcting the 1H, 13C, and 15N data from the Biological Magnetic Resonance Bank 
(BMRB). The SHIFTX program16 uses X-ray or NMR atomic coordinates to calculate NMR resonance 
frequencies. These calculated values are then compared to their counterparts in BMRB. A variety of 
statistical evaluations is performed, and any misassignments, typographical, or chemical referencing 
errors are corrected. 
 
Chemical shifts of 2162 proteins (October 2019) are categorized as HELIX, SHEET, or COIL by the 
Volume, Area, and Dihedral Angle Reporter (VADAR) server.17 The HELIX and SHEET assignments are 
based on dihedral angles18, hydrogen bonding patterns19, and geometrical constraints20. If a structure 




The RefDB data for lysine residues are plotted in histograms to illustrate the distribution of the chemical 
shifts in each conformation. These plots are compared to 1D spectra of [U-13C,15N-Lys] elastin, and the 
secondary structures are assigned using 13CO-Lys and 13Cɑ-Lys sites. The amino acids that follow Lys, 
i.e., R+1, are identified in the tropoelastin sequence, and the neighboring residues effects are calculated. 
The chemical shifts of Lys bonded to a given R+1 are then compared to 13CO-13Cɑ-Lys correlations 
obtained from a 2D DARR experiment. 
3.1.4 Variable-temperature 13C MAS NMR study 
Temperature affects both the secondary structure of an amino acid sequence and the dynamics of a 
protein. The 13C CP signal intensities increase when hydrated BLN elastin is cooled below the freezing 
point of water.21 These differences in the lineshapes may be attributed to the glass transition, i.e., the 
reversible change from a molten, rubber-like state to a brittle, glassy state. 
 
The temperature of the glass transition, Tg, depends on the hydration level of elastin.22 As the motions of 
the hydration water become restricted, the mobility of the protein is greatly reduced.23 In the dehydrated 
state, Tg is 200°C, whereas elastin at 60% hydration has Tg ~ 0°C.24  
 
Previous VT studies of alanines in the CL domains showed significant reductions in dipolar couplings and 
an increase in α-helical content below Tg.25 Generally, fast and large-amplitude motions in warm 
temperatures promote the formation of short helices. Longer helical chains are favored as the dynamics 
of the protein is attenuated below Tg. Since the CL domains primarily consist of Ala and Lys residues, 
similar dependencies are expected in the VT study of [U-13C,15N-Lys] elastin. 
 
3.1.5 Spin-lattice relaxation measurements 
Nuclear spins in a static field B0 show a net alignment of the magnetic moments along the field direction, 
typically defined as the z-axis. This equilibrium state is perturbed by an rf pulse, which rotates the net 
magnetization towards the transverse plane. Following a pulse, the bulk z-magnetization re-establishes 




Spin-lattice relaxation is an incoherent process that occurs when spins experience local fields; the 
magnitudes and orientations of these fields are not the same in different parts of the sample. If the local 
field oscillates at the Larmor frequency and has transverse components, the magnetic moment which 
experiences that field is rotated to a new direction. Alignment along the z-axis is favored, as it is the low 
energy arrangement, and the net magnetization eventually returns to its equilibrium value. In NMR of 
spin-½ nuclei, local fields are predominantly generated by the magnetic moments of other spins, i.e., the 
dipolar mechanism. 
 
Spin-lattice relaxation is characterized by a time constant, T1, which describes motion in the MHz regime, 
as opposed to T1ρ that reflects the rotating frame and typically occurs in kHz range. T1 measurements are 
used to probe overall and site-specific dynamics in polymers and proteins.26,27,28 The value of T1 is also 
crucial in NMR spectroscopy, because it determines the necessary wait time between data acquisitions 
for signal averaging. 
 
T1, can be determined in experiments relying on DP29, CP30, and rINEPT31. In the original inversion 
recovery experiment29, a 13C 180° pulse is followed by an array of delay periods,  (figure 3.4A). The 13C 
90° pulse flips the magnetization to the transverse plane for detection, and an acquisition period with 
high-power 1H decoupling follows. To determine T1 constants, peak intensities are plotted as a function of 
 and fitted to the following equation: 
 
𝐼(𝜏) =  𝑀 × (1 − 2𝑒
 
)    (Equation 3.2) 
 







Figure 3.4: Pulse sequence for (A) 13C T1 inversion recovery experiment and (B) modified 
inversion recovery with ssNOE and DP excitation.32  
Black and white rectangles represent 90° and 180° pulses, respectively. Phase cycling in B) is as follows: 
Φ1 = {x, x, y, y, -x, -x, -y, -y}; Φ2 = {x, -x, y, -y, -x, x, -y, y}; Φ3 = Φ1; Φrec = {x, -x, y, -y, -x, x, -y, y}. 
 
 
For determination of T1 constants in enriched elastin, the inversion recovery sequence is modified with 
ssNOE and phase alternation (figure 3.4B).32 The ssNOE enhancement maximizes signal intensities in 
the shortest experimental times for mobile polymers, such as hydrated elastin. Phase alternation results 
in single-exponential decay curves that end at zero intensity at  = ∞. In the odd scans (n = 1, 3, 5…), the 
first two pulses flip the magnetization from +z-direction to the -z-direction, i.e., they are equivalent to the 
180° pulse in the classic inversion recovery experiment. In the even scans (n = 2, 4, 6…), however, they 
are equivalent to a 0° pulse. Since the receiver phase is 180° in the even scans, intensities Iodd() are 
subtracted from Ieven() during the experiment. Therefore, the signal, 𝐼(𝜏), over two scans is described by 
Equation 3.3:  
56 
 
𝐼(𝜏) = 𝐼(∞) × (1 − 𝛼) × 𝑒       Equation 3.3 
 
where 𝛼 =   𝑒  , d1 stands for recycle delay, and  𝐼(∞) is the equilibrium magnetization at 𝜏 = ∞  under 
1H saturation.  
 
Unlike in the traditional inversion recovery experiment, positive intensities are obtained for all signals 
during the decays. Moreover, full recovery of magnetization is not necessary, as  𝐼(∞) = 0, not 𝑀 , i.e.,  
the resulting single-exponential decay relaxation curve does not depend on the recycle delay, which can 
be shorter than 5 × 𝑇 . Fitting model 𝐴 × 𝑒  is used where A is the amplitude of the exponential function. 
 
3.2 Materials and methods 
Solid-state NMR spectroscopy 
About 60 mg of hydrated elastin samples, prepared as described in Section 2.5, were blotted on a 
KimWipe and packed in a 4.0 mm rotor. Kel-F top and bottom spacers (Revolution NMR, Fort Collins CO) 
fitted with fluorosilicone micro o-rings (Apple Rubber Products, Lancaster NY) were used to seal the rotor 
and maintain hydration levels. No loss of water was ensured by weighing the rotors before and after each 
experiment. The packed rotors were stored in a freezer. The [ε-13C-Lys] elastin sample was not used for 
any of the experiments discussed in this chapter. 
 
The Agilent DD2 NMR console (Agilent Technologies, Santa Clara, CA) with 9.4 T wide-bore (89 mm) 
superconducting magnet (Oxford Instruments, Oxford, UK) was used for solid-state NMR measurements. 
The 1H Larmor frequency was 399.935 MHz, and a 4 mm triple-resonance (HXY) T3 magic angle 
spinning probe (Chemagnetics/Varian NMR, Ft. Collins, CO) was used. The temperature of the sample 
was calibrated using Pb(NO3)233 under MAS with 8 kHz spinning rate. The 8 kHz MAS rate was used in all 
experiments, unless stated otherwise. Sodium 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) in D2O [δ(1H) 
= 0.0 ppm at 25°C] was used as an external reference. The tetramethylsilane (TMS) scale was applied to 
reference 13C chemical shifts with hexamethylbenzene serving as an external standard [δ(13C) = 17.0 
ppm at 25°C].  
 
For 13C DP experiments performed on [U-13C,15N-Lys] and unenriched elastin samples, 4.5 μs 13C 90° 
pulse was used with a 10 s recycle delay. A Hahn echo (echo--echo) block was utilized with echo = 125 
μs. To remove dipolar (1H-13C) interactions, two-pulse phase modulation (TPPM)34 1H decoupling was 




In the variable-temperature study, [U-13C,15N-Lys] elastin was observed at 37°C, 20°C, 10°C, and 0°C via 
ssNOE/DP (figure 3.1). An initial 4.7 μs 13C 90° pulse was followed by acquisition under TPPM 1H 
decoupling.34 The ssNOE enhancement was achieved by applying 1H CW irradiation ( HB1H/2 ~ 1 kHz) 
throughout the 1.5 s recycle delay. Each spectrum is a result of 4096 scans. 
 
13C CP experiments were performed on [U-13C,15N-Lys] elastin and unenriched elastin samples at 37°C 
and -20°C. A 4.7-μs 1H 90° pulse was followed by a 1 ms contact time with recycle delay of 5 s. The B1 
field strengths for CP were set to CB1C/2 = 50 kHz and HB1H/2 = 42 kHz, so that the Hartmann-Hahn 
sideband condition is met and CB1C/2 = HB1H/2 + n*r, where r is the spinning rate of the rotor, and n 
= 1. CP field strength for 1H was ramped from 95% to 105%. A Hahn echo (echo--echo) block was utilized 
for CP with echo = 125 μs. TPPM 1H decoupling was applied during the 20 ms acquisition time with an 
applied field strength of  HB1H/2 ~ 50 kHz.  
 
In the 13C-{1H} rINEPT, 90° pulse lengths for 1H and 13C were 5.0 µs and 4.6 µs, respectively (figure 3.2). 
The recycle delay was set to 1.5 s. The initial pulse is followed by a spin-echo sequence. Typically, the 
length of  is in the order of  1 |4 ∗  𝐽 |. Delays for the first (-  - 180° -  -) and second (- ’ - 180° - ’ -) 
spin-echo blocks were set to  = 1.25 ms and ’ = 1.0 ms, respectively. TPPM 1H decoupling was used 
during the 30 ms acquisition time with an applied field strength of  HB1H/2 ~ 50 kHz. 
 
In 2D 13CO-13Cα DARR, [U-13C,15N-Lys] elastin was frozen at -20°C and spun at this temperature for 
about 40 min for equilibration (figure 3.3). An initial 4.2-μs 1H 90° pulse was followed by a 1 ms contact 
time. The CP field strengths were set to CB1C/2 = 50 kHz and HB1H/2 = 42 kHz, so that the Hartmann-
Hahn sideband condition is met and CB1C/2 = HB1H/2 + n*r, where n = 1. The CP field strength for 1H 
was ramped from 95% to 105%. For the 13CO-selective 180° pulse, refocused Selective excitatioN fOr 
Biochemical applications (r-SNOB)35 pulse (pulse width: 1063 s = 8.5*r)36 was applied with 1H CW 
decoupling (HB1H/2 = 63 kHz). The 5-ms DARR mixing time was applied to obtain mainly directly-bound 
13CO-13C correlations. Two 4.5-μs 13C 90° pulses were applied at the beginning and end of the mixing 
time. TPPM 1H decoupling was used during the 30 ms acquisition time with applied field strength HB1H/2 
~ 50 kHz. Quadrature detection in the t1 dimension was achieved by using States-TPPI with phase shifts 
of the 13C CP contact pulse and the receiver. The spectral width in the indirect dimension was set to 2000 
Hz (= × r) with the transmitter frequency at 174 ppm, for a spectral window of 164 ppm – 184 ppm. 
Nine complex points were collected in the t1 dimension corresponding to t1max = 4 ms. Two hundred fifty-
six scans were accumulated per t1 point. A 3.0-s recycle delay was used, and the total experimental time 
was 4 hours. 
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13C T1 modified inversion recovery with ssNOE/DP begins with two 13C 90° pulses, each 4.7 μs long 
(figure 3.4B). In odd scans (scan 1, 3, etc.), these two pulses are equivalent to a 180° pulse, and the z-
magnetization is flipped to the (-z)-direction. In the even scans (scan 2, 4, etc.), the effects on the 
magnetization are equivalent to a 0° pulse, i.e., magnetization is stored along the (+z)-direction. The 
lengths of delay time, , that follows were [0, 0.3, 0.5, 0.9, 1.5, 2.0, 3.0, 4.0, 5.0] s. A 4.7 μs 13C 90° read 
pulse is applied to tip the spins into the transverse plane, to allow for their detection. The 180° receiver 
phase is on even scans results in subtraction of the (2*n)th scan from the (2*n+1)th scan. TPPM 1H 
decoupling (strength γHB1H/2π ~ 50 kHz) takes place during the 30 ms acquisition time. 1H low-level CW 
irradiation (γHB1H/2π ~ 1kHz) is applied for the length of the recycle delay (3 s). 
 
Analysis of RefDB data 
RefDB38 is a secondary database that contains re-referenced 1H, 13C, and 15N chemical shift data from 
the Biological Magnetic Resonance Bank (BMRB). Briefly, the Volume, Area, and Dihedral Angle 
Reporter (VADAR) server17 assigns HELIX and SHEET secondary structures to atoms in 2,162 proteins 
in RefDB, according to dihedral angles18, hydrogen bonding patterns19, and geometrical constraints20. 
Structures that do not match the requirements for HELIX or SHEET are assigned as COIL. 
 
RefDB 13C chemical shift data for 13CO- and 13Cα-Lys are sorted and plotted in histograms. Each interval 
(or bin) spans 0.2 ppm. The height of each bar corresponding to a given bin represents the relative 
number of observations, normalized over the total number of data points in a given histogram. HELIX 
histograms are based on 3,315 (13CO-Lys) and 4,536 (13Cα-Lys) data points. COIL histograms include 
3,082 (13CO-Lys) and 4,510 (13Cα-Lys) data points. SHEET histograms include 2,191 occurrences of 
13CO-Lys and 3,066 of 13Cα-Lys. 
 
Intra-residue 13CO-13Cα correlations for lysine in HELIX, COIL, and SHEET were based on 2869, 2573, 
and 1859 available data points in RefDB, respectively. Gaussian function was created for each 13CO-13Cα 
correlation, and the final surface results from addition of these functions. The same exponential scale is 
used for the 2D DARR contour and the RefDB correlations. In both, lines represent 20, 24, 29, 35, 41, 50, 
60, 72, and 86% (going from innermost to outermost), where 100% represents the total enclosed volume. 
 
Adjustment for neighboring residue effects 
Chemical shifts accounting for secondary structure and neighboring residue effects are calculated for 
lysine in elastin. Briefly, 13C chemical shifts of Lys in random coil, δcoil(Lys), is obtained from a study of a 
model peptide, Ac-GGKGG-NH2, in denaturing conditions.37 The correction factor for each amino acid4, 
Δδ(R+1), is then added to calculate the chemical shift of coil that accounts for the neighboring residue 
effects (NRE), i.e., δcoil,NRE(Lys) = δcoil(Lys) + Δδ(R+1). Similarly, δhelix,NRE(Lys) represents the chemical 
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shifts of lysine in α-helix adjusted for NRE. Helix is calculated from the values for coil and secondary 
shifts from RefDB38 as follows: δhelix,NRE(13CO-Lys) = δcoil,NRE(13CO-Lys) + 2.06 ppm and δhelix,NRE(13Cα-Lys) 
= δcoil,NRE(13Cα-Lys) + 2.34 ppm. The obtained 13CO-13Cα correlations for each KR+1 pair are plotted, using 
Gaussian functions to reflect the relative number of occurrences in the NRSMC tropoelastin monomer. 
The volume under each crosspeak is used as a reference (100%) for the contour lines that follow 
exponential scale and represent 10, 20, 40, and 80% of the volume (going from innermost to outermost).  
 
3.3 Results and discussion 
Solid-state 13C NMR measurements of [U-13C,15N-Lys] elastin give insights into conformations and 
dynamics of lysine residues in the hydrated protein. Secondary structures are tentatively assigned, based 
on chemical shifts in RefDB. The neighboring residue effects on the isotropic chemical shifts are also 
used to assign the crosspeaks in a 2D 13CO - 13Cɑ-Lys correlation experiment. A modified inversion 
recovery measurement determines the 13C spin-lattice relaxation constants for the labeled sites in lysines 
and the crosslinks. 
3.3.1 One-dimensional 13C MAS NMR spectra 
The targeted 13C sites are observed in a DP spectrum of [U-13C,15N-Lys] elastin (figure 3.5A). However, 
lysine is a minor residue in elastin; it constitutes about 5% of the amino acids in NRSMC tropoelastin39 
and less than 1% in the mature, crosslinked protein. Even with isotopic enrichment approaching 90%, the 
signals of labeled nuclei are obscured by the remaining amino acids. 
 
The natural-abundance 13C signals (figure 3.5B) are subtracted from the spectrum of the enriched protein 
(figure 3.5A) to produce a difference spectrum (figure 3.5C), reflecting the destinations of the incorporated 
13C labels. All one-dimensional spectra presented in this chapter are processed in this way, unless stated 
otherwise. The scaling factors of the enriched and unenriched spectra are chosen to cancel the methyl 
signals (10 – 20 ppm) of unenriched amino acids in the difference spectrum. Neither lysine nor any of the 
crosslinks have methyl groups. Moreover, the identified scrambling pathways lead to enrichment of 
carbonyl of other amino acids, not the aliphatic carbons (Chapter 2). Therefore, no 13C labels are 





Figure 3.5: 13C DP/MAS NMR spectra of labeled and unlabeled elastin at 37°C. 
(A) Spectrum of [U-13C,15N-Lys] elastin, (B) spectrum of unenriched elastin, and (C) difference spectrum 
(A - B), displaying signals originating from [U-13C,15N-Lys]. Spectra (A) and (B) were each acquired with a 
recycle delay of 10 s and 1024 scans, then processed with 40 Hz line broadening. Each spectrum is 
scaled to its tallest peak. The resolved intensities in the difference spectrum (C) are assigned to the sites 





The peaks in the 13C DP/MAS NMR difference spectrum of [U-13C,15N-Lys] elastin at 37°C (figures 3.5C 
and 3.6A) are assigned to the sites in Lys, as follows. The carbonyl feature has its highest intensity at 
174.6 ppm. A weak signal is observed in the 140 - 160 ppm range, which is expected for the pyridinium 
ring of desmosine40, isodesmosine41, and other heteroaromatic carbons. The peak at 54.5 ppm is 
assigned as 13Cα-Lys. The characteristic, narrow intensity at 40.1 ppm corresponds to 13Cε of unmodified 
lysine. Its lineshape is attributed to high mobility at the terminal carbon of unmodified lysine. The 
remaining aliphatic peaks at 30.9, 27.1, and 22.9 ppm are assigned to 13Cβ-, 13Cδ-, and 13Cγ-Lys, 
respectively. 
 
Protonated carbons in mobile domains are enhanced by rINEPT (figure 3.6B). No carbonyl signal is 
observed, because polarization transfer only occurs at carbons that are bonded to protons. In comparison 
to DP and CP spectra (figure 3.6A-B), the sharp 13Cε-Lys peak is much taller than the other aliphatic 
signals in rINEPT, confirming high mobility at the end of the lysine sidechain. The 13Cα-Lys signal is 
weak, which is attributed to the rigid nature of the backbone carbons. 
 
CP selectively detects rigid regions. In the spectrum obtained at 37°C (figure 3.6C), the carbonyl feature 
is shorter than in the DP spectrum and has height comparable to 13Cα-Lys. The peak assigned as 13Cβ-
Lys has lower intensity than in DP, suggesting this site does not have as many rigid populations as other 
aliphatic carbons. The lineshapes of the remaining aliphatic carbons resemble those in DP. 
 
Due to rigidification of the protein, signal intensities greatly improve for a frozen sample of hydrated [U-
13C,15N-Lys] elastin. The lineshapes in the CP spectrum recorded at -20°C are different from those in 
experiments conducted at the physiological temperature. All peaks are broader; 13Cβ-, 13Cδ-, and 13Cγ-
Lys are not resolved. 13Cε-Lys signal is weak, confirming that the lysine sidechain loses mobility upon 
freezing. The broad, asymmetric 13Cα-Lys peak appears to consist of at least two overlapping 
populations. The signals in the heteroaromatic region of the spectrum, assigned as 13C sites in the rigid 
pyridinium ring, are clearly distinguished from noise. The backbone carbonyl feature is broader and taller 






Figure 3.6: 13C difference spectra of [U-13C,15N-Lys] elastin. 
(A) DP at 37°C acquired with recycle delay of 10 s and 1024 scans (figure 3.5C), (B) rINEPT 
measurement at 37°C with recycle delay of 1.5 s and 6144 scans, (C) CP at 37°C obtained with recycle 
delay of 5 s and 6144 scans, and (D) CP TOSS acquired at -20°C with recycle delay of 5 s, and 2048 
scans. The acquired spectra were processed with 40 Hz line broadening, and each was scaled to its 





3.3.2 Secondary structure assignments in 1D 13C NMR spectra based on RefDB data 
Solid-state NMR is a powerful and versatile technique that provides valuable information on the 
secondary structure of proteins. One-dimensional 13C NMR spectra are compared against the data in 
RefDB to predict the conformations of lysine in elastin at -20°C and 37°C. The results of the analysis are 
later used in the analysis of two-dimensional spectra. 
 
The chemical shifts of 13CO-Lys and 13Cα-Lys in RefDB are plotted in histograms (figure 3.7). Width of 
each interval (or bin) corresponds to a 0.2 ppm range. The height of each bar corresponds to the relative 
number of observations of each bin, normalized over the total number of occurrences in a given structure 
(HELIX, SHEET, or COIL). Each histogram was based on 2,000 – 4,500 data points with assigned 
secondary structures in RefDB (details are provided in Section 3.2). The bins with the highest 
occurrences in the histograms for 13CO-Lys and 13Cα-Lys in HELIX (176.6 and 57.2 ppm, respectively) 
are downfield from those of the SHEET (173.0 and 53.0 ppm) and COIL (174.2 and 54.2 ppm). The COIL 
histograms are generally broader and overlap significantly with those for SHEET. However, HELIX is 





Figure 3.7: Chemical shifts of 13CO-Lys and 13Cα-Lys in [U-13C,15N-Lys] elastin spectra and RefDB 
database. 
(A) 13C difference spectra of [U-13C,15N-Lys] elastin acquired at 37°C with ssNOE/DP, DP, rINEPT, and 
CP (37°C and -20°C). (B) Distributions of 13C chemical shifts of 13CO-Lys (left) and 13Cα-Lys (right) 
categorized as HELIX, COIL, and SHEET in RefDB. 13C-Lys resonances are sorted and categorized into 
intervals (or bins) spanning 0.2 ppm. The height of each bar reflects the relative number of observations 
of a given bin, normalized over the total number of occurrences. The sum of the bar heights in each 
histogram is 1 (or 100%). Dashed lines correspond to the highest number of occurrences in each 
histogram for HELIX (blue), COIL (pink), and SHEET (orange). 
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The DP experiment at 37°C reveals 13CO- and 13Cα-Lys peaks with the highest intensities at 174.6 and 
54.6 ppm, respectively. A sharp peak at 54.6 ppm is observed in rINEPT. The signals in CP at 37°C are 
more upfield; a broad 13CO-Lys intensity is centered at ~174 ppm and has a shoulder at ~177 ppm.  
13Cα-Lys is centered at ~ 53.5 ppm and has a downfield shoulder at ~57 ppm. At 37°C, weak intensities 
consistent with HELIX are observed in ssNOE/DP, DP, and CP at 37°C, but not rINEPT. Spectra 
recorded at this temperature are more consistent with the upfield chemical shifts of SHEET (173.0 and 
53.0 ppm) and COIL (174.2 and 54.2 ppm) than the downfield HELIX (176.6 and 57.2 ppm).  
 
COIL is the most likely predominant structure at 37°C. SHEET and COIL cannot be distinguished, based 
on the 13C chemical shifts from 1D experiments, as indicated by the histograms. However, alanines in 
crosslinking domains are mostly found in HELIX with contributions from COIL populations.7 Given Lys in 
the CL domains is typically surrounded by Ala residues, some consistency in the secondary structures of 
these two amino acids (KA) is expected. And, as no alanine population in CL domain was found in 
SHEET, it is unlikely for lysine to take that conformation. 
 
The CP lineshapes are significantly different at -20°C compared to those at 37°C. At -20°C, the 13CO-Lys 
feature is centered at ~ 175 ppm, and 13Cα-Lys is a broad peak centered at ~54.5 ppm with a distinct 
shoulder at ~57 ppm. The broad 13CO-Lys and 13Cα-Lys features overlap with all three histograms 
(HELIX, COIL, and SHEET), indicating more than one population of lysine. The downfield signals are 
aligned with HELIX, implying an increase in the helical content as the sample is frozen. HELIX is the 
dominant secondary structure only in CP spectra at -20°C.  
 
In summary, COIL appears to be dominant at the physiological temperature. Weak signals consistent with 
HELIX are also detected. According to the CP experiments at -20°C and 37°C, the helical content is 
higher at the negative temperature. SHEET and COIL chemical shifts in RefDB are not resolved, but the 
previous studies of alanines in elastin make SHEET an unlikely candidate. 
3.3.3 Secondary structures in 2D 13CO-13Cα DARR correlation 
The multiple populations observed in 1D spectra of [U-13C,15N-Lys] elastin (figure 3.7) are resolved with a 
2D DARR experiment. Two-dimensional data allows for analysis of secondary structures and neighboring 
residue effects. The observed signals originate from 13CO-13Cα pairs in the enriched lysine residues only. 




The 13CO-13Cα DARR spectrum reveals at least three populations of lysine (figure 3.8A). Skyline 
projections reflect the tallest points of the contour crosspeaks in the spectrum. The dashed lines indicate 
the peak positions of the major crosspeaks at (δ(13CO), δ(13Cα)) = (176.0, 57.1), (174.8, 54.5), and 
(172.7, 52.3) ppm, which are denoted I, II, and III, respectively. Populations I and II are clearly resolved, 
but III is relatively broad.  
 
To assign secondary structures, the 2D spectrum is compared to the correlated 13CO-13Cα chemical shifts 
for HELIX (blue), COIL (pink), and SHEET (orange) from RefDB (figure 3.8B). The data used for the 1D 
analysis (figure 3.7) is represented in form of a 2D plot. HELIX is well resolved, but COIL and SHEET 
overlap, with the latter being a broad distribution. The major population in the 2D spectrum (I) matches 
HELIX (blue). Population (II) overlaps with the RefDB correlations for a COIL (pink). The broad crosspeak 
(III) is consistent with the unresolved SHEET (orange) and COIL (pink). 
 
Chemical shifts of lysine that account for both sequence- and structure-dependent effects are predicted 
with a semi-empirical approach. The chemical shift of lysine in random coil is obtained from a model 
peptide in denaturing conditions.37 This base value is then adjusted with the correction factor for each 
R+1.4 The resulting chemical shifts for coil account for both conformation and neighboring residues 
effects. Helix is calculated from the coil values, by adding the secondary shifts from RefDB (+2.06 ppm 
for 13CO and +2.34 ppm for 13Cα).38 
 
The predictions for helix and coil are plotted in a 2D contour plot with a weighed Gaussian function that 
reflects for the number of occurrences of each KR+1 pair in the TE sequence (figure 3.8C and D). The 
most common amino acid following lysine in the NRSMC TE sequence is alanine (R+1 = A); KA is found 
19 times. The predicted crosspeaks of KX (where X = Y, V, L, S, or R) are not resolved from those of KA. 
However, KP occurs 5 times in the TE monomer and is resolved from KA and KX by 2 ppm (both 13CO-
Lys and 13Cα-Lys) in each secondary structure. 
 
Predicted chemical shifts of Lys in helix and coil match the populations observed in the 2D DARR 
spectrum (figure 3.8C).  Population (I) in the experimental spectrum overlaps with KA and KX in helix. 
Crosspeak (II) matches KA and KX in coil as well as KP in helix. KP in coil is clearly resolved from the 
remaining predictions and is consistent with population (III). 
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Coil is the most likely conformation of KP pairs. Even though KP in helix overlaps with population (II), 
proline has high helical penalty (table 3.1). This amino acid does not have a protonated nitrogen, which is 
needed for hydrogen bonding in α-helix. Moreover, the predicted chemical shifts of both 13CO-Lys and 
13Cα-Lys in sheet are in the upfield regions of the spectrum, i.e. a crosspeak at (171, 52) ppm, and no 
such signal was detected. 
 
Overall, the presence of HELIX is unambiguous. This finding is consistent with the CP results for the 
frozen sample (figure 3.7) and the previous studies of alanines.7 Signals matching COIL are also 
observed. No signal for KP in sheet confirms the assignment of COIL as a predominant secondary 






































Figure 3.8: 2D selective 13CO-13Cα DARR spectrum of [U-13C,15N-Lys] elastin at -20°C and predicted 
chemical shifts of lysine. 
(A) 13CO-13Cα correlations of Lys in [U-13C,15N-Lys] elastin. Skyline projections of both dimensions are 
shown. The three major crosspeaks are denoted (I), (II), and (III); dashed lines mark their positions. 
(B) Observed spectrum (A, gray contours) with plots of 13CO-13C correlations for HELIX (blue), COIL 
(pink), and SHEET (orange) from RefDB.  
(C) Observed spectrum (A, gray contours) with predicted 13CO-13Cα correlations. Coil (pink) is calculated 
from the reported neighboring residue effects. Helix (blue) is calculated from coil with the secondary 
shifts from RefDB: +2.06 ppm for 13CO and +2.34 ppm for 13Cα. The 2D plots are generated with 
Gaussian functions and reflect the relative number of occurrences of KR+1 pairs in the tropoelastin 
sequence. 
(D) Two-amino-acid sequences (Lys – R+1) in NRSMC tropoelastin.39 
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3.3.4 Variable-temperature study 
SsNOE/DP and CP are used in the variable-temperature study of [U-13C,15N-Lys] elastin at positive and 
negative temperatures, respectively (figure 3.9). The two different excitation schemes are chosen due to 
low intensities of CP at 37°C (figure 3.6) and broad lines in DP at negative temperatures.25 Data for 
unenriched elastin were not recorded to reduce the experimental time. Therefore, the presented spectra 
reflect all populations of 13C in [U-13C,15N-Lys] elastin and are not difference spectra. 
 
In ssNOE/DP (37°C to 0°C), peaks of unenriched amino acids are observed in addition to 13C-Lys signals. 
The asymmetric lineshape of 13CO is attributed to the contribution from 13CO-Gly, which at 37°C has a 
peak at 172.0 ppm.42 Overlapping peaks between 14 and 20 ppm correspond to methyl carbons of 
alanine, valine, and leucine. Nonetheless, intensities originating from labeled lysine are sufficiently 









Figure 3.9: Variable-temperature 13C NMR spectra of [U-13C,15N-Lys] elastin. 
SsNOE/DP and CP experiments acquired 4096 and 1024 scans, respectively. The dashed lines 
correspond to the highest position of each feature at 37°C. Each spectrum was processed with 40 Hz line 
broadening and scaled to the 13CO-Lys peak. 
 
 
The changes in chemical shifts of 13CO-Lys and the aliphatic carbons at positive temperatures are 
negligible (table 3.4). The biggest change in the chemical shift occurs for 13CO (0.3 ppm), 13Cε (0.3 ppm), 





Table 3.4: 13C chemical shifts of lysine in [U-13C,15N-Lys] elastin above 0˚C. 
Chemical shift of the tallest peak position for 13C ssNOE/DP spectra (figure 3.9) are given. The row 
designated as |Δ| shows the absolute difference in chemical shift between 37°C and 0°C for each site. 
 δ (13C) (ppm) 
Temperature 13CO 13Cα 13Cβ 13Cγ 13Cδ 13Cε 
37°C  174.3 54.6  30.7  23.1  27.1  40.2 
20°C 174.5 54.5 30.7 23.0 27.0 40.1 
10°C 174.6 54.5 30.6 23.0 27.0 40.0 
0°C 174.6 54.4 30.5 23.0 27.0 39.9 
|Δ| (37°C - 0°C) 0.3 0.2 0.2 0.1 0.1 0.3 
 
 
Studies of poly-L-lysine ([Lys]n) in helix and coil are an additional reference for resonances in different 
secondary structures (table 3.5).43 The chemical shift of 13CO is the least affected by the conformation; 
the difference between helix and coil is only 0.3 ppm. The chemical shift of 13Cδ is the most sensitive to 
conformation, having |Δ| > 4 ppm. The remaining sites differ by 1 – 2 ppm. 
 
 
Table 3.5: 13C chemical shifts of [Lys]n.43 
13C solution NMR chemical shifts of [Lys]n in D2O are shown. The row designated |Δ| (helix - coil) is the 
difference in the chemical shift of the two conformations. 
 δ (13C) (ppm) 
 13CO 13Cα 13Cβ 13Cγ 13Cδ 13Cε 
[Lys]n α-helix 174.8 55.3 31.6 23.8 30.7 41.4 
[Lys]n coil 174.5 53.6 30.7 22.4 26.5 39.5 
|Δ| (α-helix - coil) 0.3 1.7 0.9 1.4 4.2 1.9 
 
 
The chemical shifts from RefDB (section 3.3.2) and the literature [Lys]n values (table 3.5) are consistent; 
the shifts of aliphatic 13C-Lys typically vary by 1 – 4 ppm when helix and coil conformation are compared. 
In contrast, the chemical shifts for these sites in elastin at 37°C and 0°C vary by ≤ 0.3 ppm, i.e., the 13C-
Lys chemical shifts do not significantly change as the temperature is lowered to 0°C. This observation is 
consistent with the findings for the Ala residues in elastin25 as well as glass transition temperatures 




The chemical shift of 13Cα at 37ºC (54.6 ppm) appears to be in between that of helix (55.3 ppm) and coil 
(53.6 ppm) in [Lys]n (table 3.5). However, the value determined in the variable-temperature study is 
consistent with population (II) in the 2D DARR spectrum (figure 3.8), which is assigned as KA and KX in 
coil. 
 
The lineshapes of the CP spectra recorded at negative temperatures (-10°C, -20°C, -30°C) are not 
significantly different from each other. A single asymmetric peak is observed for 13Cβ, 13Cγ, and 13Cδ. 
13Cε, which is narrow and well-resolved in the DP experiments at positive temperatures, has a 
significantly lower intensity in the CP experiments of a frozen sample. The lineshape of 13Cα implies the 
presence of at least two populations with peaks at ~53.0 ppm and 57.2 ppm. The asymmetric 13CO 
feature consists of 13CO-Lys centered at 175.4 ppm and the natural-abundance backbone 13CO, typically 
observed at 173 ppm in CP of hydrated elastin at -20°C.21 
 
The chemical shifts of 13CO and the aliphatic carbons of lysine do not significantly change as the 
temperature is lowered from 0°C to -30°C (table 3.6). The |Δ| for each of these sites does not exceed 0.2 
ppm. Intensities in the heteroaromatic region (120 – 165 ppm) are detected in each of the CP spectra. 
However, the S/N is not sufficient to accurately report changes in response to temperature. 
 
 
Table 3.6: 13C chemical shifts of lysine in [U-13C,15N-Lys] elastin below 0˚C. 
Chemical shift of the tallest peak position for 13C CP spectra (figure 3.9) are given. The row designated as 
|Δ| shows the absolute difference in chemical shift between 0°C and -20°C for each site. 
 δ (13C) (ppm) 
Temperature 13CO 13Cα (helix) 13Cα (coil) 13Cβ, 13Cγ, 13Cδ, 13Cε 
- 10°C 175.5 57.1 53.0 29.3 40.0 
- 20°C 175.4 57.0 52.9 29.5 40.0 
- 30°C 175.4 57.2 53.0 29.5 40.1 
|Δ| (-30°C - (-10°C)) 0.1 0.2 0.1 0.2 0.1 
 
 
The results below 0ºC are consistent with the analysis of 1D and 2D data in the previous sections. In 
RefDB, the chemical shift with highest number of occurrences for 13Cα -Lys is 57.2 ppm for HELIX and 
53.0 ppm for COIL, which closely matches the two peaks assigned as 13Cα (helix) and 13Cα (coil) (table 
3.6). The latter two also overlap with populations (I) and (III) in the 2D spectrum obtained at -20ºC (figure 




Overall, α-helical content of lysine is higher in the frozen sample than at the physiological temperature. 
This change may be attributed to the glass transition. CP at -20°C is more efficient than DP at 37°C, but 
the latter experiment provides more detailed information about the conformations of the aliphatic carbons. 
Since 13Cβ, 13Cγ, and 13Cδ are not resolved in CP at -20°C, analysis of their secondary structures below 
the Tg is not possible. 
3.3.5 13C T1 measurement 
The T1 constants are obtained from the modified inversion recovery experiment (figure 3.4) conducted at 
37°C (table 3.7). Signal intensities are plotted against time  to give exponential decay curves. The T1 
value of each resolved site is extracted from the fitted trendline. The exponential decay fittings are 
included in Appendix IV. The determined T1 values were used to optimize the recycle delay in 
experiments described in Chapters 3 and 4. 
 
The relaxation constants range from 0.41 s for the 13Cε to 1.37 s for 13CO. The results for [U-13C,15N-Lys] 
elastin are consistent with the studies of hydrated [Lys]n, which showed fast motion increases with the 
distance from the backbone.44 The T1 value for the rigid pyridinium ring at 142.0 ppm is estimated to be 
1.40 s. However, an accurate analysis was not possible for this site, because the detected signal is too 
broad and weak. No R2 value is provided for this particular site, and the reported constant should be 




Table 3.7: T1C values for lysine in [U-13C,15N-Lys] elastin. 
T1 is estimated for the broad feature at 142 ppm (*). The uncertainties of the T1 values represent the 
standard error of regression for a given 13C site. 
 
δ (13C) (ppm) Assignment T1 (s) R2 
23.1 13Cγ-Lys 0.56 ± 0.07 0.981 
27.1 13Cδ-Lys 0.48 ± 0.03 0.994 
30.9 13Cβ-Lys 0.53 ± 0.05 0.990 
40.3 13Cε-Lys 0.41 ± 0.05 0.982 
54.7 13Cα-Lys 1.06 ± 0.15 0.983 
142.0 Pyridinium ring 1.4 (*) N/A 






The relaxation times of elastin vary greatly for different sites in this protein and are influenced by the 
hydration levels and temperature.21,45 Typically, long 13C T1 constants indicate carbons in rigid 
environments and, conversely, short T1 values are characteristic of mobile domains. The T1 values for 
hydrated [U-13C,15N-Lys] elastin at 37°C are similar to previously reported work on elastin isolated from 
bovine ligamentum nuchae (BLN).21 The aliphatic region has nearly liquid-like time constants (< 1 s), 
consistent with the high mobility of the protein.  
 
3.4 Summary and conclusions 
The [U-13C,15N-Lys] elastin sample differs from the previously explored amino acids in elastin. Due to the 
low content of Lys in the protein, difference spectra are obtained for nearly all 1D experiments. Otherwise, 
the signals of the highly enriched lysines overlap with the natural-abundance 13C populations of other 
amino acids, such as glycine, alanine, or proline. 
 
Analysis of the 1D chemical shifts of 13CO and 13Cα suggests COIL and HELIX are the dominant 
secondary structures of lysine in elastin. At 37ºC, COIL appears to be the most common conformation, 
and measurements at -20°C shows an increase in helical content as the sample is frozen. The 2D DARR 
experiment allows for selective observation of 13CO - 13Cα correlations. 
 
The 2D DARR at -20°C allows for resolution of population observed in 1D experiments. The increase of 
HELIX in the frozen sample is confirmed. Semi-empirical approach allows for predictions of chemical 
shifts that account for both structure- and sequence-dependent effects. The populations corresponding to 
KA and KX pairs are assigned as both helix and coil. The dominant conformation of KP is coil.  
 
A variable-temperature study (-30°C to 37°C) is consistent with the conformational analysis of 1D and 2D 
spectra. An increase in the helical content is evident when temperature is lowered from 0°C to -10°C. This 
finding is consistent with the studies of Ala in the crosslinking domains.25 At warmer temperatures, shorter 
helices are formed due to the fast, large-amplitude motions of elastin. As the dynamics of the protein is 
attenuated, longer helices form in the crosslinking domains.  
 
The spin-lattice relaxation measurements used the modified inversion recovery pulse sequence to 
determine the 13C T1 values in the lysine residues of elastin. This experiment is chosen as it effectively 
enhances the signals of low-γ nuclei in rapid motion and provides single-exponential decays in a shorter 
time. The determined values ranged from 0.41 s for the mobile 13Cε to 1.37 s for the rigid 13CO-Lys. A 
rough estimate for the pyridinium ring signal at 142 ppm is 1.4 s. The results are consistent with high 




Solid-state NMR is a powerful, versatile technique that allows for studies of secondary structures and 
dynamics of the lysine in elastin. The post-translational modification products, i.e., crosslinks, introduce a 
layer of complexity absent in the previous studies of other amino acids in this protein. Nonetheless, a 
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QUALITATIVE AND QUANTITATIVE ANALYSIS OF 




Selective isotopic labeling of lysines and lysine-derived crosslinks in elastin improves sensitivity and 
resolution in the ssNMR experiments. Without incorporation of NMR-active nuclei, signals of these rare 
residues are too weak to be distinguished from the rest of the protein or are not detected at all. Targeted 
enrichment overcomes these obstacles, allowing for characterization of crosslinks. 
 
SsNMR spectroscopy is not limited by protein size, solubility, or ability to crystalize. Insoluble elastin, 
close to the one found in vivo, is studied, rather than a hydrolysate or enzymatically cleaved peptides. 
Crosslinks are observed in their native state, following a gentle purification protocol, minimizing the bias 
from side reactions. Since NMR spectroscopy is non-destructive, a single labeled sample is sufficient for 
an unlimited number of experiments. 
 
In this Chapter, crosslinks are detected in native, enriched NRSMC elastin. Various NMR experiments are 
conducted to find the optimal conditions for observation of all the labeled sites. The 13C signals are 
assigned, based on solution NMR data and predicted chemical shifts (Section 4.3.1). Lysine and its 
derivatives are quantified in two enriched samples of elastin (Section 4.3.2). Attempts to characterize 










4.1.1 CP-based quantitative ssNMR measurements 
Traditional CP experiments are non-quantitative for samples with carbons in different chemical 
environments.1 The competing effects of the carbon-proton cross-polarization time constant (TCH) and the 
proton spin-lattice relaxation time constant in the rotating frame (T1ρH) govern the dynamics in this 
excitation scheme. In typical solids, TCH is determined by the strength of the 1H - 13C coupling. Spin 
diffusion among protons dictates the T1ρH, which characterizes the 1H polarization decay. Carbons that 
are bonded to hydrogen generally have stronger dipolar couplings than the nonprotonated ones, and 
hence, short TCH values. Conversely, carbons not attached to hydrogen or in structural groups with 
significant mobility (e.g. methyl rotor) have weaker couplings and longer TCH. Thus, signal intensities for 
sites with different TCH constants are unevenly enhanced in CP. 
 
Modified CP sequences benefit from the magnetization transfer from 1H to 13C while allowing for 
quantitative measurements.2,3,4 To observe and quantify the rare crosslinks in intact elastin, the 
enhancement of S/N provided by CP is necessary. In the resulting spectra, peaks areas correspond to 
the number of spins in the respective sites, allowing for quantification of the resolved features. 
 
Quantitative Cross Polarization (QUCP)4 allows for quantitative measurements of enriched samples with 
adjacent 13C-13C sites, such as [U-13C,15N-Lys] elastin. The pulse sequence begins with a 90° 1H pulse 
followed by a CP mixing time (figure 4.1). The magnetization transfer from 1H to 13C spins favors carbons 
with short TCH values. Then, a 90° 13C pulse rotates the magnetization to the z-direction, and a dipolar 
assisted rotational resonance (DARR) mixing period follows. The polarization is redistributed through 13C-
13C spin diffusion and flipped for detection with another 13C 90° pulse. The resulting 13C QUCP spectrum 
provides quantitative data. 
Figure 4.1: Pulse sequence for 13C-{1H} QUCP experiment.4  
The phase cycling was modified from the original paper as follows: Φ1 = {x, -x}; Φ2 = {y}; Φ3 = {y, -y, y, -y, 
x, -x, x, -x}; Φ4 = {-x, x, -x, x, y, -y, y, -y}; Φ5 = {x, -x, -y, y, x, -x, -y, y}; Φrec = {y, -y, x, -x, y, -y, x, -x}. 
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Composite-Pulse Multiple Cross Polarization (ComPmultiCP) is a quantitative experiment optimized for 
samples with dilute labels, such as [ε-13C-Lys] elastin.2,3 It begins with successive loops of an excitation 
pulse followed by a mixing time and a storage pulse (figure 4.2). The composite 13C pulses improve 
accuracy of the quantitative data as the method becomes less sensitive to Hartmann-Hahn mismatch, 
flip-angle error, and resonance offset.3 Short CP blocks minimize the non-uniform signal loss due to T1ρH 
relaxation. The tz period allows 1H magnetization to recover and reverses the loss due to proton spin 
diffusion. The 13C magnetization increases at different rates, depending on TCH, but reaches a steady-
state at all 13C sites at the end of the loop. The final (sixth) CP contact time is shorter to eliminate any 
residual effects of non-uniform T1ρH relaxation. Lastly, a spin echo sequence follows on the 13C channel, 
removing the effects of inhomogeneities in the B0 field by refocusing the magnetization, which reaches a 
maximum after the second delay r. 
 
Figure 4.2: Pulse sequence for 13C-{1H} ComPmultiCP experiment.3  
Black and white rectangles represent 90° and 180° pulses, respectively. A Hahn echo block is utilized 
before the acquisition with delays  equal to the rotor period, r. 
 
 
A single, CP-based, quantitative measurement is not applicable to both [U-13C,15N-Lys] elastin and [ε-13C-
Lys] elastin. The first sample has consecutive 13C-13C spins, whereas 13C nuclei is bonded to NMR-
inactive 12C in [ε-13C-Lys] elastin. Thus, 13C spin diffusion occurs in [U-13C,15N-Lys] elastin but not in [ε-
13C-Lys] elastin. In QUCP, the unevenly enhanced magnetizations are redistributed during DARR mixing 
time. This equilibration is too slow without uniform enrichment of lysine, and the 13C spins in [ε-13C-Lys] 
elastin are quantified with ComPmultiCP instead. In this experiment, the effects of differential T1ρ 
relaxation are overcame with multiple CP blocks followed by 1H repolarization periods, tz. Spin diffusion in 
[U-13C,15N-Lys] elastin would contribute to (uneven) equilibration of the magnetization of protonated and 
nonprotonated carbons during tz, resulting in a non-quantitative spectrum. 
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4.2 Materials and methods 
[U-13C,15N-Lys] elastin, [-13C-Lys] elastin, and the natural-abundance protein were prepared as described 
in Chapter 2. The typical sample mass, rotor inserts, and other parameters for ssNMR experiments are 
included in Chapter 3. Conditions and parameters for 13C DP and CP experiments are the same as in 
Section 3.2, unless stated otherwise. 
 
For CP TOSS5 experiment at -20°C, samples of [U-13C,15N-Lys], [-13C-Lys], and unenriched elastin were 
frozen at -20°C and spun at this temperature for about 40 min for equilibration. A 4.2-μs 1H 90° pulse was 
followed by a 1 ms contact time. Spinning sidebands were suppressed by the TOSS-4 sequence5 with 9.2 
μs 13C 180 pulses (figure 1.8). The delays between these pulses were: t1 = 0.1226r, t2 = 0.0773r, t3 = 
0.2236r, t4 = 1.0433r, t5 = 0.7744r (where r is the rotor period). After t5, TPPM 1H decoupling was 
applied during the 20 ms acquisition time with an applied field strength of  HB1H/2 ~ 60 kHz. 
 
The 13C QUCP4 experiment was performed on [U-13C,15N-Lys] elastin and the unenriched elastin at -20°C 
(figure 4.1). A 3.5-μs 1H 90° pulse was followed by a 1-ms contact time with a 5-s recycle delay. DARR6 
mixing was applied for 500ms with B1 field strength of HB1H/2 = 1*r = 8 kHz. The two 13C pulses (90°Φ4, 
90°Φ5) had width of 4.7 μs. TPPM 1H decoupling was applied during the 20 ms acquisition time with an 
applied field strength of  HB1H/2 ~ 60 kHz. 
 
13C ComPmultiCP3 experiment was conducted on [-13C-Lys] elastin and unenriched elastin at -20°C 
(figure 4.2). A composite 13C 90-180 excitation pulse was followed by CP with 1 ms contact time and 
then a 13C 180-90 storage pulse. After time tz (800 ms), this sequence is repeated four more times. 
After the final (sixth) CP block, with contact time of 500 μs, a Hahn echo block follows (τecho = r = 125 μs). 
TPPM 1H decoupling was applied during the 20 ms acquisition time with an applied field strength of  
HB1H/2 ~ 60 kHz. A recycle delay of 5 s was used. The complete phase cycling can be found at 
http://www.ksrlab.org/nmrksr/. 
 
The Agilent 600 MHz DD2 NMR spectrometer equipped with a 3 mm Direct Detect™ NMR probe was 
used to obtain 13C solution NMR spectra of a commercially available mixture of DES and IDES (Cat. No. 
MD687, Elastin Products Co., Inc., Owensville, MO). Five mg of the mixture were dissolved in 1 mL of 
water. One hundred seventy-six μL of this standard were used in the derivatization reaction with FDLA 
(Chapter 2). The remaining solution was lyophilized overnight, yielding about 4 mg of dry sample. The 
powder was dissolved in MeOH-d4 and placed in a 3 mm NMR tube. The spectrum (14976 scans, 3 s 





The 15N DP experiment was performed on [U-13C,15N-Lys] elastin sample at 37°C. A 9.3 μs 15N 90° pulse 
was followed by a Hahn echo (echo--echo) block with τecho = 20 μs. To remove dipolar (1H-15N) 
interactions, 1H TPPM decoupling was used. The recycle delay was 10 s.  
 
The 15N CP experiment was performed on [U-13C,15N-Lys] elastin sample at -20°C. A 4.2 μs 1H 90° pulse 
was followed by a 3.5 ms contact time with recycle delay of 5 s. The CP field strengths were set to 
NB1N/2 = 28 kHz and HB1H/2 = 36 kHz, so that the Hartmann-Hahn sideband condition is met and 
NB1N/2 = HB1H/2 + n*r, where r is a spinning rate of the rotor, and n = 1. The CP field strength for 1H 
was ramped from 95% to 105%. A Hahn echo (echo--echo) block was utilized for CP with τecho = 125 μs. 
 
4.3 Results and discussion 
Samples of isotopically labeled elastin were isolated and purified in mild conditions, allowing for 
quantitative ssNMR studies of an intact protein. Briefly, a digest with cyanogen bromide (CNBr) in formic 
acid was used. CNBr cleaves proteins at methionine, which is not found in the NRSMC elastin (Appendix 
II). Then, extraction with guanidinium hydrochloride and mercaptoethanol followed. Guanidinium salt is a 
chaotropic agent that disrupts hydrogen bonds, whereas mercaptoethanol reduces disulfide bridges. 
Cysteine, the only residue forming the latter, does not appear in the elastin sequence. This step is 
intended to remove cysteine-containing proteins, such as collagen. 
 
Lysine and lysine-derived crosslinks are observed and quantified in intact elastin with ssNMR 
spectroscopy. 13C signals are assigned based on solution NMR data for the well-characterized DES and 
IDES, and predictions for the rare bi- and tri-functional crosslinks. Quantitative CP-based measurements 
allow for analysis of crosslinking content in the samples of enriched elastin. 15N NMR spectra do not 
provide sufficient S/N for studies of modified lysines. 
4.3.1 Predictions of 13C chemical shifts of crosslinks 
To interpret and assign the complex NMR spectra, external 13C chemical shift references for the 
crosslinks are needed. DES and IDES have been extensively characterized, due to their potential to 
serve as biomarkers for COPD.7,8,9 However, chemical shift predictions are the only available option for 




Mnova Best algorithm was used to predict the 13C chemical shifts for the crosslinks (Appendix III). This 
method combines two different algorithms, hierarchically ordered spherical environment (HOSE) and 
neural networks. HOSE is suitable for query structures that are well-represented in the literature. The 
neural network tends to be more accurate for novel compounds that are not commonly found in 
databases. Combining the two approaches results in more accurate and precise predictions.   
Plots of the predicted 13C chemical shifts of crosslinks reveal resolved regions in the spectra (figure 4.3). 
The aldehyde carbonyl (13COCHO) signals around 200 ppm are unique to Lya, AA, and CPN. Peaks in the 
135 – 165 ppm range arise from bi-, tri-, and tetrafunctional crosslinks. The pyridinium ring carbons have 
predicted chemical shifts of 141, 144, and 151 ppm in DES and 137, 139, 146, and 151 ppm in IDES. 
Bifunctional AA also has signals in this region, at 153 ppm (both labeling schemes) and 142 ppm (only [U-
13C,15N-Lys] elastin). DLNL also overlaps with the pyridinium ring signals (160 ppm). MDES has a well-
resolved signal at 128 ppm, which can be used to confirm presence of this trifunctional crosslink in 
elastin.  
 
The remaining regions are too crowded in [U-13C,15N-Lys] elastin spectra for assignments, but are 
informative in [ε-13C-Lys] sample. For example, the crosslinking aliphatic signals (20 – 60 ppm) are not 
resolved in [U-13C,15N-Lys] elastin spectra, but [ε-13C-Lys] sample allows for observation of unmodified 
lysine at 40 ppm. The 13Cε site in modified Lys residues is shifted downfield to the 13Cα region (48 – 60 
ppm) and indicate presence of crosslinks, e.g., LNL (48 ppm), DLNL (57 ppm), MDES (49 ppm, 52 ppm), 
DES (64 ppm), or IDES (62 ppm). The chemical shifts of 13COBB (178 – 174 ppm) are not resolved in [U-
13C,15N-Lys] elastin, but this region can be used to quantify scrambling to 13CO-Gly (Chapter 2) in [ε-13C-






Figure 4.3: Predicted 13C chemical shifts of lysine and lysine-derived crosslinks in [U-13C,15N-Lys] 
elastin and [ε-13C-Lys] elastin. 
Red denotes signals originating from 13Cε in [ε-13C-Lys] elastin. Both red and black signals are expected 
in the spectra of [U-13C,15N-Lys] elastin. Predictions for lysine and crosslinks (figure 1.4) were obtained 






To validate the predictions, a solution 13C NMR spectrum of a commercially available DES and IDES 
mixture was obtained (figure 4.4). 13COBB peaks are observed at 176 and 177 ppm. Three signals at 142, 
144, and 161 ppm are consistent with the pyridinium ring predictions. Peak at 63 ppm is assigned as 
13Cε. The overlapping 13Cα signals are observed in the 56 – 57 ppm range. The upfield signals (23 – 33 
ppm) arise from aliphatic 13Cβ, 13Cγ, and 13Cδ. A peak at 49.5 ppm corresponds to methanol. 
 
An unidentified peak at 41.5 ppm is likely a contaminant. The purity of the sample reported by the 
manufacturer is 99.5%. The commercially available DES and IDES mixture is obtained from BLN elastin 
and is assessed via amino acid analysis. Non-amino acid contaminants could be present in the 
commercial standard. 
 
Figure 4.4: Solution 13C NMR spectrum of DES and IDES mixture. 
Spectrum for a 4 mg sample in MeOH-d4 was obtained from 14976 scans. Baseline correction (Whittaker 
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Overall, the predicted chemical shifts are consistent with the experimental data, but minor discrepancies 
are observed, in particular in the pyridinium ring data (tables 4.1 - 4.2). Mnova provides significantly lower 
values for C6DES, C6IDES, and C5IDES than reported for synthetic products8,9 and observed for the 
commercial standard (figure 4.4). The predicted value for C6DES (150.9 ppm) is upfield compared to those 
of the synthetic (161.0 ppm) and the commercial (161.0 ppm) crosslinks. The calculated chemical shift for 
C6IDES (138.9 ppm) is also more upfield than the experimental data for the synthetic (146.7 ppm) and the 
commercial (144.1 ppm) products. The predicted shift of C5IDES (136.0 ppm) is also underestimated 
compared to those of the synthetic (141.3 ppm) and the commercial (142.5 ppm) product. The 
experimental values are generally consistent with each other, i.e., Mnova predictions for C6 and C5 sites 
are incorrect. 
 
Additional inconsistencies are found in the Mnova predictions for an aliphatic carbon (C8DES) and carbonyl 
carbons (C24DES and C31IDES). C8DES has a predicted chemical shift of 27.9 ppm; the value reported for 
this site is 32.7 ppm for the synthetic product. Both C24DES and C31IDES have calculated shifts of 174.7 
and 178.8 ppm, respectively, whereas 174.7 ppm is reported for both of these two sites in the literature. 
The values measured for the commercial sample are in between, at 176.9 and 176.1 ppm, respectively. 
 
The chemical shifts IDES in the commercial mixture do not match the predictions or the synthetic product 
values.9 The Mnova values for C1 and C4 are 136.9 and 150.7 ppm, respectively, and match the 
chemical shifts of the synthetic IDES (139.4 and 154.2 ppm). However, the closest peaks in the NMR 
spectrum of the commercial product (figure 4.4) are at 142.5 and 161.0 ppm. This finding implies the 
commercial sample actually consisted mostly of DES. 
 
In summary, Mnova chemical shift predictions are useful tools in interpretation of the 13C spectra of 
labeled elastin. Some of signals originating from bi-, tri-, and tetrafunctional crosslinks are expected to be 
sufficiently resolved to allow for their unambiguous assignment. The predictions for the pyridinium ring 
carbons are not consistent with the solution NMR data for commercial and synthetic product. Thus, 











Table 4.1: Predicted and experimental 13C chemical shifts of DES. 
Difference exceeding 4ppm in red. 
 
  
                                                     
i From Ref.8: Total synthesis of COPD biomarker desmosine that crosslinks elastin. 
ii From solution NMR of commercial product (figure 4.4). 
Carbon 
Atom 
13C Chemical Shift (ppm) 










(A - D) 
1 C 140.8 142.3 -1.5 142.5 -1.7 
2 CH 144.8 144.2 0.6 144.1 0.7 
4 CH 144.8 144.2 0.6 144.1 0.7 
5 C 140.8 142.3 -1.5 142.5 -1.7 
6 C 150.9 161.0 -10.1 161.0 -10.1 
7 CH2 63.7 63.0 0.7 62.9 0.8 
8 CH2 27.9 32.7 -4.8 27.6 0.3 
9 CH2 25.5 24.0 1.5 23.8 1.7 
10 CH2 31.0 32.4 -1.4 32.4 -1.4 
11 CH 58.0 55.3 2.7 56.6 1.4 
12 C 177.7 174.7 3.0 176.1 1.6 
15 CH2 29.1 28.1 1.0 28.1 1.0 
16 CH2 29.1 28.1 1.0 28.1 1.0 
17 CH2 30.8 32.4 -1.6 32.3 -1.5 
18 CH 54.3 55.2 -0.9 56.6 -2.3 
19 C 176.4 174.6 1.8 176.1 0.3 
22 CH 58.9 55.2 3.7 56.6 2.3 
24 C 179.4 174.7 4.7 176.9 2.5 
26 CH2 30.8 31.6 -0.8 32.1 -1.3 
27 CH 54.3 55.2 -0.9 56.8 -2.5 
28 C 176.4 174.6 1.8 176.1 0.3 
34 CH2 28.9 28.1 0.8 28.8 0.1 
35 CH2 24.6 23.6 1.0 23.4 1.2 
































Table 4.2: Predicted and experimental 13C chemical shifts of IDES. 
Difference exceeding 4ppm in red. 
Carbon 
Atom 
13C Chemical Shift (ppm) 










(F - I) 
1 C 136.9 139.4 -2.5 142.5 -5.6 
2 CH 146.1 143.8 2.3 144.1 2.0 
4 C 150.7 154.2 -3.5 161.0 -10.3 
5 C 136.0 141.3 -5.3 142.5 -6.5 
6 CH 138.9 146.7 -7.8 144.1 -5.2 
7 CH2 61.5 58.6 2.9 62.9 -1.4 
8 CH2 29.1 31.0 -1.9 28.8 0.3 
9 CH2 23.2 21.9 1.3 23.4 -0.2 
10 CH2 31.3 30.5 0.8 30.6 0.7 
11 CH 56.7 55.0 1.7 56.6 0.1 
12 C 177.3 175.0 2.3 176.9 0.4 
15 CH2 29.8 27.9 1.9 27.6 2.2 
16 CH2 31.0 27.9 3.1 27.6 3.4 
17 CH2 31.2 31.5 -0.3 32.1 -0.9 
18 CH 54.4 54.8 -0.4 56.8 -2.4 
19 C 176.2 174.4 1.8 176.1 0.1 
22 CH2 32.1 31.4 0.7 32.1 0.0 
23 CH 54.5 54.7 -0.2 56.8 -2.3 
24 C 176.3 174.4 1.9 176.1 0.2 
27 CH2 28.2 28.7 -0.5 28.1 0.1 
28 CH2 22.2 24.3 -2.1 23.4 -1.2 
29 CH2 30.6 30.8 -0.2 32.1 -1.5 
30 CH 57.8 54.8 3.0 56.8 1.0 





                                                     
iii From ref. 9: Pr(OTf)3-promoted Chichibabin pyridine synthesis of isodesmosine in H2O/MeOH. 



































4.3.2 Assignment of 13C chemical shifts 
Observation of the rare crosslinks requires selection of an appropriate excitation scheme and 
experimental conditions. DP at 37°C offers quantitative spectra, but the signal intensities in the 
heteroaromatic region (135 – 165 ppm) are insufficient for analysis (figure 3.6). However, signals 
originating from crosslinks are detected in CP spectra of hydrated elastin sample cooled to -20°C (figure 
4.6).  
 
Lysine and crosslinking signals are not observed in the CP TOSS spectrum of unlabeled elastin (figure 
4.6 A). The 13COBB peak has the highest intensity at 173 ppm. The broad feature centered around 129 
ppm arises from the heteroaromatic rings of phenylalanine and tyrosine. The peaks at δ(13C) = 43, 49, 53, 
57, 60 ppm originate from the natural-abundance 13Cα of amino acids, with the most upfield one assigned 
as glycine. Peaks at 30 and 25 ppm arise predominantly from the aliphatic carbons of valine and proline. 
The methyl signals (δ(13C) = 19, 16 ppm) originate from valine and alanine.10 
 
The CP TOSS spectrum of [U-13C,15N-Lys] elastin confirms high isotopic enrichment (figure 4.6B). The 
lineshape is significantly different compared to the spectra of unenriched elastin. Two broad intensities 
centered at 198 and 142 ppm are observed. The aliphatic region has peaks at 57 and 53 ppm, which are 
consistent with the spectra of the unlabeled sample, and two additional features with the tallest points at 
40 and 29 ppm. 
 
Even with ~90% isotope incorporation, natural-abundance signals need to be subtracted from those of the 
enriched proteins. Scaling factors are chosen to cancel the signals originating from methyl groups of 
valine and alanine in the upfield region of the spectrum (figure 4.6C). Similarly, the aliphatic signals 
upfield from the narrow 13Cε-Lys feature in the [ε-13C-Lys] elastin spectrum (figure 4.6D) are cancelled in 








Figure 4.5: 13C CP TOSS NMR spectra of labeled and unlabeled elastin at -20°C. 
(A) Spectrum of unenriched elastin, (B) spectrum of [U-13C,15N-Lys] elastin, and (C) difference spectrum 
(B - A) showing signals originating from [U-13C,15N-Lys] (figure 4.5C). (D) Spectrum of [ε-13C-Lys] elastin 
and (E) difference spectrum (D - A) displaying signals originating from [ε-13C-Lys]. Spectra (A), (B), and 
(D) were acquired with recycle delay of 5 s and 2048 scans, then processed with 40 Hz line broadening. 






The predicted and experimental chemical shifts were used to assign the difference spectra of [U-13C,15N-
Lys] elastin (figure 4.5C). Aldehyde carbonyl peak (13COCHO) at 198 ppm could correspond to Lya, AA, 
and CPN. Lya is highly reactive; it is either present in very low quantities11 or not found at all.12 CPN is so 
rare, it has never been quantified.13 Therefore, AA is the most likely source of any signal in this region. 
The backbone carbonyl peak (13COBB) is observed at 176 ppm. The broad features ranging from 135 to 
166 ppm arise from the pyridinium rings of DES, IDES, and possibly less common crosslinks that contain 
this moiety. Some 13Cε of unsaturated bifunctional crosslinks, such as AA, DMDES, or DLNL, possibly 
contribute to this feature as well. A broad signal between 115 and 136 ppm is consistent with the 
predictions for MDES (128 and 134 ppm) and other rare crosslinks such as CPN (133 ppm) and PEN 
(130 ppm). Heteroaliphatics ranging from 45 to 60 ppm include both the 13Cα populations and 13Cε in 
modified Lys. The broad feature in the saturated aliphatics region between centered at 29 ppm originates 
from the remaining carbon atoms (13Cβ, 13Cγ, 13Cδ) of lysine and crosslinks. A sharp peak at exactly 40.0 
ppm corresponds to 13Cε of unmodified Lys. 
 
Due to the natural linewidths of solid proteins, the peaks for the aliphatic 13C sites in [U-13C,15N-Lys] 
elastin are not resolved (figure 4.5C, 20 – 38 ppm). Additional complexity arises from the overlap of peaks 
from the crosslinks, many of which have very similar structures. A spinning sideband of 13Cα has intensity 
comparable to those of the crosslinking peaks at the spinning rate of 8 kHz, and its expected chemical 
shift is at ~135 ppm, complicating the interpretation of the crowded, heteroaromatic region. 
 
The CP TOSS spectrum of [ε-13C-Lys] elastin is consistent with high levels of isotopic enrichment 
determined via HPLC-MS assay (figure 4.5D). The aliphatic region of the spectrum agrees with the 
lineshape of the unenriched elastin (figure 4.5A), with the exception of an additional, narrow peak at 40 
ppm, assigned as 13Cε of unmodified lysine. The downfield region of the spectrum reveals peaks with 
δ(13C) = 123, 131, 144, 159, and 198 ppm. Carbonyl of elastin is centered around 173 ppm. 
 
CP TOSS difference spectrum of [ε-13C-Lys] complements the results for [U-13C,15N-Lys] elastin. 
Assignments are based on the Mnova Best predictions and the chemical shifts reported for synthetic DES 
and IDES (figure 4.6). The distinct features and the possible corresponding 13Cε sites in the crosslinks are 
highlighted with color. The weak, broad feature between 80 and 93 ppm is denoted as “ǂ” and does not 







Figure 4.6: 13C CP TOSS NMR difference spectrum of [ε-13C-Lys] elastin and 13Cε chemical shifts of 
lysine and crosslinks. 
The 13Cε chemical shifts of lysine and crosslinks are compared to the CP TOSS results (figure 4.5E). 
DES8 and IDES9 list experimental chemical shifts, remaining entries reflect predictions (figure 4.4). Color 
scheme corresponds to the different types of chemical environments (figure 1.4).  
 
 
The putative aldehyde peak centered at 198 ppm was observed in the spectrum of [ε-13C-Lys] elastin 
spectra (figure 4.6). This feature also appears in the spectrum of [U-13C,15N-Lys] elastin (figure 4.5C), but 
not the unenriched protein (figure 4.5A). Therefore, this signal originates from a crosslink, rather than 
contaminant or a side product of the protein purification. Lya, AA, and CPN, the possible sources of this 




The lineshapes in the 149 – 166 ppm region are different in the spectra of the [ε-13C-Lys] elastin 
compared to [U-13C,15N-Lys] elastin (figure 4.5C), as only three out of five pyridinium carbons in DES and 
IDES originate from Cε-Lys. Two resolved features with tallest positions at 144 and 159 ppm are 
observed. Similarly, the lineshape of the broad signal in the 120 – 136 ppm range, assigned as alkenes, 
looks different in the [ε-13C-Lys] elastin spectrum. A more distinct peak at 123 ppm, which is the closest 
match for MDES, is detected. The weak, broad signal; with the highest point at 59 ppm is the 13Cε that 
shifted downfield as a result of crosslink formation. This spectrum has only one clearly defined peak 
upfield, the 13Cε of unmodified Lys centered at 40.0 ppm. No peak around 35 – 36 ppm, as predicted for 
ADES and CPN, is observed, implying these crosslinks were absent from the NRSMC elastin sample. 
 
An unassigned weak, broad feature is observed between 80 and 93 ppm (figure 4.6). This signal is not 
present in the spectra of unenriched elastin (figure 4.5A), which implies that it originates from 13Cε-Lys. 
To exclude the possibility of incomplete sideband suppression by TOSS, another spectrum was obtained 
at 6 kHz (figure 4.8). The signal is still present, and its overall lineshape has not changed. This feature 
most likely corresponds to a hydroxyl group of a minor lysine modification product that either has not 
been isolated yet or was a by-product of the extraction and purification procedures. 
 
Figure 4.7: 13C CP TOSS NMR difference spectra of [ε-13C-Lys] elastin at varied MAS rates. 
Spectra were obtained for [ε-13C-Lys] elastin and natural-abundance protein at (A) 8 kHz (figure 4.5E) and 
(B) 6 kHz spinning rate and 1232 scans. A weak, broad feature at 80 – 95 ppm is highlighted in orange. 
Intensities are adjusted to the tallest peak at 40 ppm. Dashed lines correspond to the highest position of 





Overall, the lineshapes of the remaining sites in the spectra do not appear significantly changed at the 
lower spinning rate. The only exception is the shoulder at 154 ppm (figure 4.7A), which is not as distinct 
at 6 kHz (figure 4.7B). However, results are inconclusive as this deviation may be due to different S/N in 
the two experiments.  
4.3.3 Quantification of crosslinks 
Two different CP-based experiments were needed, as the two the isotopically labeled samples are not 
compatible with a single approach. [U-13C,15N-Lys] elastin is uniformly enriched, whereas [ε-13C-Lys] 
elastin has a single 13C label per lysine equivalent. In QUCP of [U-13C,15N-Lys] elastin, a broadband 
homonuclear recoupling technique redistributes the unevenly enhanced magnetizations of 13C spins. This 
method relies on 13C spin diffusion, which is too slow without uniform 13C enrichment. Therefore, 
ComPmultiCP is instead used for [ε-13C-Lys] elastin. This method combines multiple CP steps separated 
by 1H repolarization periods that erase the uneven loss of 1H magnetization due to the differential T1ρ 
relaxation. Polarization transfer from 1H to 13C results in a local magnetization loss of 1H spins, but this 
effect is cancelled by 1H spin diffusion. Surrounding 1H spins constitute a large reservoir of 1H 
magnetization in samples that are not uniformly enriched. In addition, ComPmultiCP spectrum of [U-
13C,15N-Lys] elastin would not be quantitative due to 13C spin diffusion that would contribute to 
equilibration of the magnetization of carbons 
 
QUCP quantifies the labeled sites in [U-13C,15N-Lys] elastin (figure 4.8A). The experiment was first 
optimized with a sample of U-13C,15N-Lys (10% w/w in unenriched lysine). After 500 ms mixing time, the 
enhancement factors for all the 13C sites were almost uniform (within 3% error). This error is consistent 
with the one reported for U-13C,15N-Tyr.4 To further evaluate the accuracy of the measurement, the 
number of 13C nuclei in the backbone carbonyl (13COBB) is compared to the remaining labeled sites. 
13COBB centerband and its sidebands are adjusted to a total area of 1.04 (red), which accounts for the 
intensities from 167 to 182 ppm and includes the ± 1 spinning sidebands from 87 to 115 ppm and 247 to 
262 ppm. Due to scrambling (Chapter 2), about 0.04 of 13CO-Gly residues are present for each 13CO-Lys. 
These two 13CO populations are not resolved; hence, the carbonyl feature is normalized to 1.04. The rest 
of the spectrum (gray) consists of signals coming from the remaining five labeled carbons of lysine (13Cα, 
13Cβ, 13Cγ, 13Cσ, 13Cε), and their products of the post-translational modification. The obtained ratio (1.00 : 
4.89) is close to the theoretical one (1.00 : 5.00). The unaccounted difference (5.00 - 4.89 = 0.11) implies 




Figure 4.8: Integrated difference spectra of quantitative 13C-{1H} CP/MAS NMR experiments. 
(A) QUCP (difference) spectrum of [U- 13C,15N-Lys] elastin. The total area of the backbone carbonyls (red, 
1.04) reflects the contributions of 13CO-Lys (1.00) and 13CO-Gly (0.04). All other sites (gray) have a total 
area of 4.89. 
(B) Alternate illustration of integrated QUCP spectrum of [U-13C,15N-Lys] elastin (figure 4.8A). The total 
(centerband + ssbs) intensity of the backbone carbonyls (red) is scaled to 39.6 (13CO-Lys, 38.0; 13CO-Gly, 
1.6). 
(C) ComPmultiCP spectrum of [ε-13C-Lys] elastin showing integration of resolved regions. Sum of the 
integrated areas (excluding 13CO-Gly) is adjusted to 38.0. 
Spectra were obtained at -20C with 1024 scans (A, B) and (C) 1536 scans, and then processed with 40 
Hz line broadening. Integrated areas are shown above respective peaks and include the area of any 
corresponding spinning sideband (*). Each spectrum is scaled to its tallest peak. Color scheme in B and 





QUCP of [U-13C,15N-Lys] elastin and ComPmultiCP of [ε-13C-Lys] elastin spectra provide quantitative 
information about the destinations of the labels from the enriched lysine, i.e., unmodified lysines and the 
crosslinks (figure 4.8A-C). Areas under each resolved site are integrated to reflect the relative populations 
of 13C in each chemical environment. 13CO-Lys feature is normalized to 38.0 to reflect the number of 
lysine equivalents per 836 residues in the NRSMC tropoelastin (TE) monomer (figure 4.8B). Similarly, the 
sum of all the integrated areas (excluding 13CO-Gly) is adjusted to 38.0 in the ComPmultiCP spectrum of 
[ε-13C-Lys] elastin (figure 4.8C).  
 
The experimental results for both labeling schemes are summarized and compared to the theoretical 
values for elastin with no crosslinks and with all Lys residues modified to (I)DES or AA (tables 4.3 - 4.4). 
Each lysine equivalent consists of 6 carbons, hence a total of 38 × 6 = 228 13C sites is expected in the 
spectrum of [U-13C,15N-Lys] elastin. The presented approach accounts for 221 of these (table 4.3 column 
I), which corresponds to ~3% experimental error, and this value is used to determine the uncertainty of 
the integrated areas in QUCP. The uncertainty of the ComPmultiCP results for [ε-13C-Lys] elastin (3%) is 
based on the reported enhancement factors.3  
 
 
Table 4.3: Integrated areas in QUCP spectrum of [U-13C,15N-Lys] elastin. 
13C chemical shift range used in QUCP spectrum (figure 4.8B) includes spinning sidebands for the 
respective centerbands (shown in parenthesis). The area of 13COBB-Lys (marked with *) is normalized to 











All Lys modified to 
(I)DES 
All Lys modified to 
AA 
10 - 45 
(-70 - (-35), 
103 - 115) 
110.1 ± 3.3 152 95.0 95 
45 - 70 
(-35 - (-12)) 
52.8 ± 1.6 38 47.5 38 
115 - 135 5.5 ± 0.2 0 0.0 0 
135 - 150 
(215 - 230) 
10.2 ± 0.3 0 38.0 19 
150 - 165 1.9 ± 0.1 0 9.5 19 
167 - 182 
(87 - 102, 
247 - 262) 
38.0* ± 1.1 38 38.0 38 
191 - 203 2.3 ± 0.1 0 0.0 19 




Table 4.4: Integrated areas in ComPmultiCP spectrum of [ε-13C-Lys] elastin. 
13C chemical shift range used in QUCP spectrum (figure 4.8C) includes spinning sidebands for the 
respective centerbands (shown in parenthesis). Color denotes chemical environments (figures 4.6 and 












All Lys modified to 
(I)DES 
All Lys modified to 
AA 
34 - 46 7.4 ± 0.2 38 0.0 0 
46 - 68 6.5  ± 0.2 0 9.5 0 
79 - 95 2.3 ± 0.1 0 0.0 0 
119 - 136 
(203 - 210) 
3.9 ± 0.1 0 0.0 0 
135 - 150 
(219 – 230) 
4.6 ± 0.1 0 19.0 0 
150 - 165 
(68 - 79, 
231 – 245) 
8.4 ± 0.3 0 9.5 19 
167 - 183 0.9 ± 0.1 0 0.0 0 
191 - 203 
(113 - 119, 
271 – 282) 
4.8 ± 0.1 0 0.0 19 
TOTAL 38.1 ± 1.1 38 38 38 
 
 
The broad feature with the point of highest intensity at 29 ppm, has an area of 110 and originates from 
the aliphatic carbons (spectrum 4.8B, purple). 13Cε and 13Cδ carbons of lysine are shifted downfield when 
in a crosslink. Without crosslinking, the total area of this region is 4 times that of 13CO-Lys, to account for 
four aliphatic carbons: 13Cβ, 13Cγ, 13Cδ, and 13Cε (table 4.3). The experimental value of 110 is lower than 
the expected 152 if no crosslinks were present, which confirms post-translational modification. This 
aliphatic region in the spectrum of [ε-13C-Lys] elastin (figure 4.8C) only has one sharp peak at 40 ppm, 
assigned as 13Cε in unmodified lysine. According to the spectral data, 7.4 Lys residues per TE monomer 
do not undergo post-translational modification. This value is higher than the reported 5 unmodified lysine 
residues per TE monomer after 8 weeks of NRSMC cell culture.14 
 
The 13Cα-Lys lineshape (45 – 70 ppm) is broad, with 2 peaks at 55 and 57 ppm (figure 4.8B only, pink). It 
includes an unresolved contribution from 13Cε-Lys in crosslinks. The latter population is clearly observed 
in [ε-13C-Lys] elastin spectra at 60 ppm (4.8C, pink). Without crosslinking, the ratio of the areas 13CO-Lys 
to 13Cα-Lys is 38 : 38, or 1 : 1 (table 4.3). Due to 13Cε contributions to the 13Cα region, the experimental 
ratio is 38 : 53 (~1 : 1.4).  
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A broad feature between 115 and 135 ppm is observed in the spectrum of [U-13C,15N-Lys] elastin (figure 
4.8B, light green). It is assigned to MDES (as confirmed by CP TOSS) as well as the spinning sidebands 
of the aldehyde (blue) and 13Cα (purple). The integrated area is 5.5, but due to overlap with the 
sidebands, MDES content cannot be established. In the [ε-13C-Lys] spectrum, this feature has a peak at 
123 ppm, and the integrated area is 3.9 (figure 4.8C, light green). The smaller area is explained by the 
loss of contribution from 13Cα spinning sideband. 
 
The peaks at 142 and 159 ppm of the QUCP spectrum of [U-13C,15N-Lys] elastin (figure 4.8B, dark green) 
are primarily assigned to the pyridinium ring carbons of DES and IDES. In [ε-13C-Lys] elastin, these two 
populations are present in a 8.4 : 4.6 (~2 : 1) ratio, whereas the upfield component is greater in the [U-
13C,15N-Lys] sample (1.9 : 10.2, or ~ 1 : 5). If the only crosslinks formed were DES and IDES, then the 
ratio of the two peaks would be 1 : 4 in [U-13C,15N-Lys] elastin and 1 : 2 in [ε-13C-Lys] elastin. Therefore, 
the uniformly labeled sample contains the tetrafunctional crosslinks almost exclusively. In contrast, the 
integrated areas of the two lineshapes of the [ε-13C-Lys] sample reflect additional contributions from other 
crosslinks, likely DLNL, AA, DMDES, PEN, or NDES. The differences between samples are expected, as 
others have shown that crosslinking in elastin varies from sample to sample, with some exhibiting, e.g., 
greater DES (over IDES) or greater bifunctional (vs. tetrafunctional) moieties.12,15,16  
 
The integrated areas of the (mostly) pyridinium carbons are used to quantify the crosslinks in elastin 
(table 4.5). If all carbons in the 150 - 165 ppm region of [U-13C,15N-Lys] elastin originate from DES and 
IDES, the normalized area of 1.9 corresponds to 7.6 Lys equivalents of (I)DES per TE monomer. If, 
instead, the 135 - 150 ppm region is used for the analysis, again assuming no contribution from bi- and 
trifunctional crosslinks, then there are 2.5 (I)DES residues (or 10.2 Lys equivalents) per monomer. 
Similarly, the peak at 143 ppm in the [ε-13C-Lys] spectrum has area of 4.6 (figure 4.8C), which translates 
to 9.2 Lys equivalents of (I)DES per TE monomer. The feature between 150 and 165 ppm has implies 8.4 
(I)DES residues (33.6 Lys equivalents) per TE monomer, which is not probable. This overrepresentation 
cannot be attributed to an experimental error as 13Cε in the (I)DES ring that is assigned to this peak is 
nonprotonated. The magnetization is initially transferred from 1H nuclei in the ComPmultiCP experiment, 
meaning this 13C population is likely to be underrepresented if the experiment was not truly quantitative. 
The most likely cause of the discrepancy between the two labeled samples is a larger number of 





Table 4.5: Quantification of unmodified Lys, (I)DES, and AA in elastin. 
Chemical shift range used for the integrals is provided in the first column. Color denotes different 















34 – 46 N/A 7.4 ± 0.2 Lys N/A 7.4 ± 0.2 
135 – 150 10.2 ± 0.3 4.6  ± 0.1 (I)DES 10.2 ± 0.3 9.2 ± 0.2 
150 – 165 1.9 ± 0.1 8.4 ± 0.3 (I)DES 7.6 ± 0.4 33.6 ± 1.0 
191 – 203 2.3 ± 0.1 4.8 ± 0.1 AA 4.6 ± 0.2 9.6 ± 0.2 
 
 
The reported quantity of (I)DES ranges from 1.7 to 12.5 Lys equivalents per TE monomer, depending on 
the quantification method, tissue type, species, and age of the animal.17,18 The results of NMR 
quantification are within this range (table 4.5), except for the discussed outlier. Amino acid analysis of 
NRSMC elastin determined 6 Lys equivalents per TE monomer.14 The values obtained in ssNMR may be 
higher as a result of the non-destructive methods used, and signals originating from bifunctional 
crosslinks contributing to the heteroaromatic region of the spectrum.  
 
The peaks at 198 ppm in both spectra (figure 4.8B and 4.8C, blue) are assigned to an aldehyde. The 
interpretation of the area under these features depends on the assignment. The content of the highly 
reactive Lya is considerable only during the early stages of growth and is generally low otherwise. 
Therefore, AA is more likely source of this peak, and the area corresponds to 4.6 lysine equivalents in [U-
13C,15N-Lys] elastin and 9.6 in [ε-13C -Lys] elastin (table 4.5). The quantity is larger in the latter, providing 
further evidence for higher number of bifunctional crosslinks in that sample. The reported values for AA 
range from 1.2 to 5.8 Lys equivalents.17,19  
 
                                                     
v From Figure 4.8. 
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The small broad peak between 79 and 95 ppm in [ε-13C-Lys] elastin spectrum is not a spinning sideband. 
Presence in CP TOSS experiments, as well as spectra recorded at a different spinning rate (figure 4.7), 
reject this hypothesis. None of the reported crosslinking compounds in the [ε-13C-Lys] elastin sample has 
a chemical shift in this region. The area (2.3) is included in the total normalized to 38.0. The chemical shift 
is consistent with a hydroxyl group attached to 13Cε, which may be a result of a side reaction during the 
protein purification procedures. 
 
The ComPmultiCP spectrum, unlike QUCP of the uniformly labeled sample, allows for a clear observation 
of scrambling to 13CO-Gly (figure 4.8C). When the difference is generated to cancel out the signals of the 
natural-abundance aliphatics (13Cα, 13Cβ, 13Cγ), a small signal remains in the 13COBB region. This feature 
corresponds to 0.9 glycine residues per TE monomer, which is lower than the enrichment level 
determined by HPLC-MS assay, but within the same order of magnitude. The results are consistent with 
scrambling to 13CO-Gly through the glycine synthase pathway. 
 
The exact identities and quantities of bi- and trifunctional crosslinks are ambiguous, given spectral 
overlap and the various possible products of the post-translational modification. However, presence of a 
multitude of lysine derivatives is undeniable. Theoretical considerations of crosslinked tropoelastin with 
only one type of modification (either (I)DES or AA) prove that a single compound cannot account for the 
number of the detected 13C populations (tables 4.3 – 4.4). 
 
Overall, it is demonstrated that ssNMR can be used for observation and quantification of crosslinks in 
elastin without the use of destructive methods. Unlike the previous crosslinking studies, the reported 
values do not have the bias resulting from hydrolysis, and other harsh processing techniques. The main 
drawback of the presented approach is the spectral overlap. However, the data from the two labeling 
schemes gives insights into the complex system of crosslinks. 
4.3.4 15N NMR spectra of [U-13C,15N-Lys] elastin 
Similar to 13C, the 15N chemical shifts are sensitive to the environment, and can be used to assign the 
secondary structures. 15Nε -Lys and 15NH-Lys features are detected in CP echo at -20°C and DP echo at 
37°C of [U-13C,15N-Lys] elastin (figure 4.9). In both spectra, the peaks are centered at 32 and 118 ppm, 
respectively. The 15Nε -Lys feature is narrow in the DP spectrum (FWHM = 68 Hz) and has a much lower 





Figure 4.9: 15N NMR spectra of [U-13C,15N-Lys] elastin. 
(A) DP echo spectrum acquired at 37°C and 1382 scans. (B) CP echo spectrum obtained at -20°C and 
4096 scans. Dashed lines correspond to the highest peak positions in (A). Both spectra were processed 
with 40 Hz line broadening, and their intensities were normalized to the tallest peak. 
 
 
The 15N chemical shifts of crosslinks are resolved from the amino group and the 15Nε of unmodified Lys. 
The expected 15N chemical shift range for the pyridinium ring of DES and IDES is 210 – 230 ppm, based 
on the calculated chemical shift for a model compound with this moiety, N-ethylpyridine (figure 4.10).20 No 













The reason for poor signal intensities is the low sensitivity of the 15N nuclei (table 1.2). The relative 
sensitivity of 15N is only 40% of that of 13C. Given that 13C signals for most of the crosslinks are weak, the 
poor S/N in 15N spectra is expected. The 15N signals are too weak to be detected, even with uniform 
isotopic enrichment. 
 
4.4 Summary and conclusions 
Bi-, tri-, and tetrafunctional crosslinks are observed and quantified in ssNMR spectra of intact, native 
elastin. Quantification of (I)DES, AA, and unmodified lysine is performed with CP-based measurements. 
The unmodified lysine content in [ε-13C-Lys] elastin is 7.4 residues per TE monomer. Both QUCP and 
ComPmultiCP detect an aldehyde peak, tentatively assigned as AA (4.6 - 9.6 Lys equivalents). The 
quantity of (I)DES was 7.6 - 10.2 Lys equiv. per TE monomer. About 6.4 Lys equivalents of 13Cε is shifted 
downfield when in crosslink, overlaying with the signals of 13Cα. The presence of MDES is confirmed by 
CP TOSS, but this crosslink is not quantified due to overlapping signals with spinning sidebands in the 
quantitative experiments. No characteristic aliphatic 13Cε signals for ADES and CPN were observed, 
implying these crosslinks were not present in the NRSMC sample. 
 
Scrambling to 13CO-Gly in [ε-13C-Lys] elastin, which was determined by the HPLC-MS assay in Chapter 2, 
is confirmed by the ssNMR data. According to the ComPmultiCP spectra, about 0.9 Gly residues per TE 
monomer are enriched. Scrambling to 13CO-Gly in [U-13C,15N-Lys] elastin could not be determined, as 
13CO-Gly is not resolved from 13COBB-Lys. 
 
15N ssNMR spectra of [U-13C,15N-Lys] elastin do not provide sufficient intensities for studies of the rare 
crosslinks.  The naturally low relative sensitivity of 15N nuclei does not allow for a sufficient signal-to-noise 
ratio for conclusive results. Peaks corresponding to 15N in unmodified Lys, both in the backbone and 15Nε 
are observed. 15N CP Echo at -20°C offers better signal intensities than the 15N DP Echo experiment at 
37°C.  
 
Overall, it is demonstrated that ssNMR can be used for quantification of (I)DES in native elastin without 
employing destructive methods. The exact identity and quantity of bi- and trifunctional crosslinks is 
ambiguous, given the overlapping signals and multiple possible compounds. However, the presence of 
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CHAPTER 5  
SUMMARY AND CONCLUDING REMARKS 
 
 
The elasticity and resilience of elastin are crucial for the proper function of vertebrate tissue. In particular, 
the importance of lysine-derived crosslinks is clear. Undercrosslinked elastin – associated with genetic 
disorders1, induced copper-deficiency2, or inhibition of LOX activity3 – lacks the elasticity that is critical for 
various life processes.4,5 To better understand the role of crosslinks, various studies focused on isolation, 
characterization, and quantification of these lysine derivatives.6,7,8,9,10 However, none of these 
approaches utilized intact protein, and the analysis of crosslinks after hydrolysis or enzymatic cleavage 
may have limited accuracy.11 
 
Strategic isotopic labeling paired with ssNMR is a versatile approach that provides quantitative, structural, 
and dynamical information on native elastin’s lysines and lysine-derived crosslinks. The four major amino 
acids of this protein have been enriched using the neonatal rat smooth muscle cell (NRSMC) line and 
then characterized by ssNMR spectroscopy.12,13,14 However, unlike the lysines in this study, the glycines, 
alanines, prolines, and valines of elastin do not undergo post-translational modification. The enrichment 
of lysine is straightforward since this amino acid is essential; direct substitution results in high 
incorporation of the isotopically labeled residues (>87%). However, the assessment of the labeling – how 
much of the lysines and their derivatives are enriched, and if the other residues were affected – required 
a modified approach. The analysis of the MS results had to account for partially enriched crosslinks and 
products of incomplete Marfey’s derivatization. Also, the possible sites of scrambling were identified 
based on the catabolic pathways of lysine, but only minor enrichment of glycine (<2%) was detected. 
 
13C chemical shifts from one- and two-dimensional (1D) measurements led to tentative assignments of 
lysines in the contexts of sequence and secondary structure (Chapter 3). In the simplest 1D experiments, 
CP selects rigid regions, rINEPT enhances mobile domains, and DP reflects all 13C sites, regardless of 
mobility. The lineshapes of the major features indicate that there are at least two dominant populations, 
assigned as random coil and α-helix. The helical content increases as the temperature is lowered to  
-20°C. These results are consistent with the previous studies of alanines, which reported helix and coil to 
be the predominant conformations of the crosslinking domains and higher helical content at -20°C.13 
Alanine is the most common neighboring residue of lysine, hence structural similarity is expected.  
105 
 
Two-dimensional (2D) correlation spectroscopy of the crowded 13CO-13Cα regions reveals at least three 
populations of lysine. Comparison to the RefDB15 chemical shifts of 13CO- and 13Cα-Lys in different 
secondary structures confirms the conclusions drawn from the 1D experiments. The observed 
populations are assigned based on the semi-empirical approach that accounts for both sequence- and 
structure-dependent effects. The chemical shifts of KA and KX (where X = Y, V, L, S, and R) are resolved 
from those of KP. The predicted values for KA and KX in both α-helix and random coil as well as KP in 
coil match the three major populations detected in the 2D DARR spectrum. No KP pairs in β-sheet 
conformation were observed. The 2D experiment complements the 1D measurements as it reflects 13CO-
13Cα of lysine only and provides more resolution.  
 
The complex system of lysine-derived crosslinks was characterized by quantitative experiments 
performed on [U-13C,15N-Lys] elastin and [ε-13C-Lys] elastin. In quantitative cross-polarization (QUCP)16 
and composite pulse multiple CP (ComPmultiCP)17 spectra, the integrated peak areas are proportional to 
the number of spins in each chemical environment, unlike “conventional” CP (Chapter 3). (CP at -20°C is 
an optimal excitation scheme for observation of the rare crosslinks, but these spectra over-represent 
protonated carbons.)  
 
The number(s) of unmodified lysine, allysine aldol, and (iso)desmosine per tropoelastin (TE) monomer in 
the labeled samples of native elastin were determined, and other bi- and trifunctional crosslinks were 
detected. Elastin’s unique desmosine and isodesmosine constituted 7.6 – 10.2 Lys equivalents per TE 
monomer. About 7 residues of unmodified lysine were detected. Spectra of [ε-13C-Lys] elastin confirmed 
that the signal at 198 ppm originates from 13Cε and that the most likely crosslink was allysine aldol (4.6 – 
9.6 Lys equivalents).  
 
In summary, solid-state NMR offers valuable insights into the structure of native elastin, focusing here on 
the lysines and the crosslinking domains in which they are found. Quantification of lysines and the 
crosslinks in native elastin by ssNMR yielded results that were consistent with the previously reported 
values for hydrolysates18,19,20,21; notably, it is the first known quantitative report for intact elastin. 
Quantification of Lys and the crosslinks by LC/MS and ssNMR may be extended to more elastin samples 
with more complex labeling schemes involving this amino acid, which will further enhance our 
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COMPOSITION OF NRSMC GROWTH MEDIA 
 
Table AI.1: Composition of Growth Media for NRSMC Cultures. 
 




Dulbecco’s Modified Eagle’s Medium (DMEM) – low glucose Sigma – Aldrich D6046 87 
Fetal Bovine Serum GIBCO 26140 10 
Sodium Pyruvate, 100mM (100x) GIBCO 11360 1 
Antibiotic – Antimycotic (100x) GIBCO 15240 1 




Table AI.2: Composition of Non-Essential Amino Acids (NEAA) (100x) (Gibco, #11140). 
 
Amino Acid Concentration (mg/L) 
Glycine 750 
L-alanine 890 
L-asparagine  1320 
L-aspartic acid 1330 


























(Sigma - Aldrich, #D6046) 
Lysine-free DMEM for 
enriched samples 
(Gibco, #A2493901) 
Inorganic Salts   
CaCl2 0.2 0.2 
Fe(NO3)3 • 9 H2O 0.0001 0.0001 
MgSO4 0.09767 0.09767 
KCl 0.4 0.4 
NaHCO3 3.7 3.7 
NaCl 6.4 6.4 
NaH2PO4 0.109 0.109 
Amino Acids   
L-arginine • HCl 0.084 - 
L-cysteine • 2 HCl 0.0626 0.0626 
L-glutamine 0.584 - 
Glycine 0.03 0.03 
L-histidine • HCl • H2O 0.042 0.042 
L-isoleucine 0.105 0.105 
L-leucine 0.105 0.105 
L-lysine • HCl 0.146 - 
L-methionine 0.03 0.03 
L-phenylalanine 0.066 0.066 
L-serine 0.042 0.042 
L-threonine 0.095 0.095 
L-tryptophan 0.016 0.016 
L-tyrosine • 2 Na • 2 H2O 0.10379 0.10379 
L-valine 0.094 0.094 
Vitamins   
Choline chloride 0.004 0.004 
Folic acid 0.004 0.004 
Myo-Inositol 0.0072 0.0072 
Niacinamide 0.004 0.004 
D-pantothenic acid • ½ Ca 0.004 0.004 
Pyridoxine • HCl 0.00404 0.00404 
Riboflavin 0.0004 0.0004 
Thiamine • HCl 0.004 0.004 
Other   
D-glucose 1.0 - 
Phenol red • Na 0.0159 - 






Table AI.4: Lysine-free DMEM Supplementation  
 
  Cell Culture 
Component Concentration 
(g/L) 
[U-13C,15N-Lys] [ε-13C-Lys] Control 
(Unenriched) 
L-lysine • HCl 0.146 No No Yes 
[U-13C,15N-Lys] • 2 HCl 0.181* Yes No No 
[ε-13C-Lys] • 2 HCl 0.175* No Yes No 
L-arginine • HCl 0.084 Yes Yes Yes 
L-glutamine 0.584 Yes Yes Yes 
D-glucose 1.0 Yes Yes Yes 
Phenol red • Na 0.11 Yes Yes Yes 
 
 





AMINO ACID COMPOSITION OF TROPOELASTIN FROM CULTURED 
NEONATAL RAT SMOOTH MUSCLE CELLS (NRSMC) 
 
 















Table AII.1: Amino Acid Composition of NRSMC tropoelastin.i 
Amino Acid Number of Residues % of Residues 
Glycine 311 37.2 
Alanine 164 19.6 
Proline 93 11.1 
Valine 75 9.0 
Leucine 52 6.2 
Lysine 38 4.5 
Tyrosine 23 2.8 
Isoleucine 21 2.5 
Threonine 17 2.0 
Serine 11 1.3 
Phenylalanine 11 1.3 
Glutamine 9 1.1 
Arginine 7 0.8 
Cysteine 2 0.2 
Aspartic Acid 1 0.1 
Asparagine 1 0.1 
TOTAL: 836 100 
 
i Pierce, R. A.; Deak, S. B.; Stolle, C. A.; Boyd, C. D., Heterogeneity of rat tropoelastin messenger-RNA revealed by 
cDNA cloning. Biochemistry 1990, 29, 9677-9683. 




PREDICTED 13C CHEMICAL SHIFTS OF LYSINE-DERIVED 
CROSSLINKS 
 
Mnova Best algorithm was used for all predicted chemical shift. Error reported by the software is included. 
 




Table AIII.2: Predicted 13C chemical shifts of allysine. 
Atom Shift (ppm) Error (ppm) 
1 C 177.7 3.0 
2 CH 58.0 5.3 
5 CH2 30.3 5.8 
6 CH2 23.5 5.8 
7 CH2 42.1 6.1 
8 CH 200.9 4.4  
 
 
Table AIII.3: Predicted 13C chemical shifts of allysine aldol. 
Atom Shift (ppm) Error (ppm) 
1 C 177.7 3.0 
3 CH 58.0 5.3 
4 CH2 31.0 5.8 
5 CH2 23.0 4.8 
6 CH2 28.6 4.0 
7 CH2 40.1 3.6 
Atom Shift (ppm) Error (ppm) 
1 C 177.7 3.0 
2 CH 58.0 5.3 
5 CH2 30.3 5.8 
6 CH2 25.0 5.8 
7 CH2 29.3 5.8 
8 CH 153.2 8.8 
9 C 141.8 10.9 
10 CH 194.6 4.6 
12 CH2 26.3 5.5 
13 CH2 29.5 5.8 
14 CH 54.4 5.3 




Table AIII.4: Predicted 13C chemical shifts of dehydrolysinonorleucine. 
Atom Shift (ppm) Error (ppm) 
1 CH2 34.1 5.5 
2 CH 160.3 7.7 
4 CH2 56.6 6.2 
5 CH2 28.9 5.8 
6 CH2 23.6 5.8 
7 CH2 30.3 5.8 
8 CH 58.0 5.3 
10 C 177.7 3.0 
13 CH2 25.5 5.8 
14 CH2 31.0 5.8 
15 CH 58.1 5.3 






Table AIII.5: Predicted 13C chemical shifts of lysinonorleucine. 
Atom Shift (ppm) Error (ppm) 
1 C 177.7 3.0 
2 CH 58.0 5.3 
3 CH2 31.0 5.8 
4 CH2 23.0 4.8 
5 CH2 28.1 5.8 
6 CH2 48.3 5.3 
10 CH2 48.3 5.3 
11 CH2 28.1 5.8 
12 CH2 23.0 4.8 
13 CH2 31.0 5.8 
14 CH 58.0 5.3 








Table AIII.6: Predicted 13C chemical shifts of merodesmosine. 
Atom Shift (ppm) Error (ppm) 
1 CH2 28.2 4.6 
2 CH 127.6 6.9 
3 C 133.6 11.6 
4 CH2 52.2 4.8 
6 CH2 49.0 6.2 
7 CH2 28.3 4.8 
8 CH2 23.6 3.7 
9 CH2 30.7 5.9 
10 CH 56.1 5.6 
12 C 177.0 4.9 
15 CH2 32.0 3.6 
16 CH2 29.7 5.8 
17 CH 54.9 5.6 
19 C 176.3 4.9 
22 CH2 25.2 4.3 
23 CH2 30.8 5.8 
24 CH 56.9 5.6 


















Table AIII.7: Predicted 13C chemical shifts of dehydromerodesmosine. 
Atom Shift (ppm) Error (ppm) 
1 CH2 29.3 5.8 
2 CH 147.7 10.2 
3 C 136.7 7.5 
4 CH 157.1 10.9 
6 CH2 58.1 6.2 
7 CH2 28.9 5.8 
8 CH2 25.5 5.8 
9 CH2 31.0 5.8 
10 CH 58.0 5.3 
12 C 177.7 3.0 
15 CH2 29.0 5.5 
16 CH2 29.5 5.8 
17 CH 54.4 5.3 
19 C 176.4 3.0 
22 CH2 25.0 5.8 
23 CH2 30.3 5.8 
24 CH 58.1 5.3 


















Table AIII.8: Predicted 13C chemical shifts of desmosine. 
Atom Shift (ppm) Error (ppm) 
1 C 140.8 10.9  
2 CH 144.8 10.9  
4 CH 144.8 10.9  
5 C 140.8 10.9  
6 C 150.9 10.9  
7 CH2 63.7 6.6 
8 CH2 27.9 5.8 
9 CH2 25.5 5.8 
10 CH2 31.0 5.8 
11 CH 58.0 5.3  
12 C 177.7 3.0 
15 CH2 29.1 5.8 
16 CH2 29.1 5.8 
17 CH2 30.8 5.8 
18 CH 54.3 5.3  
19 C 176.4 3.0 
22 CH 58.9 4.0 
24 C 179.4 3.1  
26 CH2 30.8 5.8 
27 CH 54.3 5.3  
28 C 176.4 3.0 
34 CH2 28.9 5.8 
35 CH2 24.6 5.8 















Table AIII.9: Predicted 13C chemical shifts of isodesmosine. 
Atom Shift (ppm) Error (ppm) 
1 C 136.9 6  
2 CH 146.1 7.4 
4 C 150.7 9.1 
5 C 136.0 8.2 
6 CH 138.9 7.0 
7 CH2 61.5 9.0 
8 CH2 29.1 4.6 
9 CH2 23.2 4.2 
10 CH2 31.3 5.9 
11 CH 56.7 5.6 
12 C 177.3 4.9 
15 CH2 29.8 5.2 
16 CH2 31.0 3.8 
17 CH2 31.2 5.8 
18 CH 54.4 5.6 
19 C 176.2 4.9 
22 CH2 32.1 5.9 
23 CH 54.5 5.6 
24 C 176.3 4.9 
27 CH2 28.2 5.2 
28 CH2 22.2 4.6 
29 CH2 30.6 5.9 
30 CH 57.8 4.9 















Table AIII.10: Predicted 13C chemical shifts of cyclopentenosine. 
Atom Shift (ppm) Error (ppm) 
1 C 132.8 7.5  
2 C 175.4 7.7  
3 CH2 36.1 5.5  
4 CH 47.3 6.2  
5 C 212.0 5.2  
7 CH2 24.0 5.8 
8 CH2 23.8 5.8 
9 CH2 30.3 5.8 
10 CH 58.9 4.0 
12 C 179.4 3.1  
15 CH2 27.5 5.5  
16 CH2 28.6 5.5  
17 CH2 28.5 5.5  
18 CH2 29.9 5.8 
19 CH 54.4 5.3  
21 C 176.4 3.0 
24 CH 56.3 6.1  


















Table AIII.11: Predicted 13C chemical shifts of neodesmosine. 
Atom Shift (ppm) Error (ppm) 
1 C 138.8 7.5  
2 CH 142.7 10.9  
4 CH 142.7 10.9  
5 C 138.8 7.5  
6 CH 137.0 7.8 
7 CH2 63.7 6.6 
8 CH2 27.9 5.8 
9 CH2 25.5 5.8 
10 CH2 31.0 5.8 
11 CH 58.0 5.3  
13 C 177.7 3.0 
16 CH2 32.5 5.8 
17 CH2 31.2 5.8 
18 CH 54.3 5.3  
20 C 176.4 3.0 
23 CH2 32.5 5.8 
24 CH2 31.2 5.8 
25 CH 54.3 5.3  

















Table AIII.12: Predicted 13C chemical shifts of allodesmosine. 
Atom Shift (ppm) Error (ppm) 
1 C 139.9 7.5  
2 CH 145.0 10.9  
4 CH 145.0 10.9  
5 C 139.9 7.5  
6 C 155.5 10.9  
7 CH2 63.7 6.6 
8 CH2 27.9 5.8 
9 CH2 25.5 5.8 
10 CH2 31.0 5.8 
11 CH 58.0 5.3  
13 C 177.7 3.0 
16 CH2 29.3 5.8 
17 CH2 30.8 5.8 
18 CH 54.3 5.3  
20 C 176.4 3.0 
23 CH2 29.3 5.8 
24 CH2 30.8 5.8 
25 CH 54.3 5.3  
27 C 176.4 3.0 
30 CH 40.3 6.1  
31 CH2 34.8 4.8 
32 CH2 29.9 4.8 
33 CH2 29.4 5.8 
34 CH2 28.5 5.5  
35 CH 56.3 6.1  
37 C 175.6 5.8 
40 CH2 26.6 5.8 
41 CH2 31.1 5.8 
42 CH 58.1 5.3  












Table AIII.13: Predicted 13C chemical shifts of pentasine. 
Atom Shift (ppm) Error (ppm) 
1 C 137.4 7.5  
2 CH 143.7 10.9  
4 C 153.3 10.9  
5 C 137.7 7.5  
6 CH 136.2 7.8 
7 CH2 61.1 7.6  
8 CH2 28.0 5.8 
9 C 130.3 7.5  
10 CH 136.7 7.8 
11 CH2 29.2 5.8 
12 CH2 25.0 5.8 
13 CH2 25.5 5.8 
14 CH2 31.0 5.8 
15 CH 58.0 5.3  
17 C 177.7 3.0 
20 CH2 27.6 5.8 
21 CH2 28.6 5.8 
22 CH 54.4 5.3  
24 C 176.4 3.0 
27 CH2 29.1 5.8 
28 CH2 30.8 5.8 
29 CH 54.3 5.3  
31 C 176.5 3.0 
34 CH2 32.5 5.8 
35 CH2 31.2 5.8 
36 CH 54.4 5.3  
38 C 176.6 3.0 
41 CH2 30.3 5.8 
42 CH 58.1 5.3  
















































Figure AIV.1: Exponential decay plots for each 13C-Lys in [U-13C,15N-Lys] elastin. 
OriginPro 2018b software was used for the exponential fittings. Output is shown on the right of each 
graph. 
